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in Hypoxic Ovine Cerebral Arteries 
by 
Richard Burdette Thorpe 
Doctor of Philosophy, Graduate Program in Biochemistry 
Loma Linda University, June2016 
Dr. William J Pearce, Chairperson 
 
Nitric oxide (NO) and its precursors have been used clinically to induce 
vasorelaxation long before the specific mechanism of how this operates was understood. 
With the discovery in 1977 of the influence of NO on guanylate cyclase, and the 
subsequent elucidation of the NO pathway, the role of cyclic guanidine monophosphate 
(cGMP)-dependent protein kinase (PKG) has been shown to be the main mediator of NO-
induced vasorelaxation. Less well understood is the behavior of this pathway in 
conditions of long term hypoxia (LTH). It was later shown that LTH attenuates the ability 
of PKG to mediate vasorelaxation. How this operates is the focus of this investigation. 
Here we tested the hypothesis that LTH attenuates NO-induced vasorelaxation by 
reducing the ability of PKG to phosphorylate its target proteins that mediate vascular 
relaxation and contraction. A prominent target of PKG involved with vasorelaxation is 
the BK channel alpha protein. To examine the influence of LTH on PKG-induced 
vasorelaxation, and to demonstrate the relative influence of the BK channel in these 
conditions, we used carotid and middle cerebral arteries from normoxic and chronically 
hypoxic fetal and adult sheep. These arteries were denuded of endothelium and used in 
concentration-response relations using 5-HT as a contractant and measured contractile 
 xvi 
force. To measure the relative influence of the BK channel in these arteries, we used the 
selective BK channel blocker iberiotoxin. From this we demonstrated that while hypoxia 
affects both BK and non-BK channel mechanisms, the influence of LTH on the BK 
channel is dominant in the loss of PKG-mediated vasorelaxation.  We also examined 
whether hypoxia attenuates PKG expression and specific activity, as well as the BK 
channel alpha and beta proteins. Using Western blotting and enzyme kinase activity 
assays, we learned that LTH has a modest influence on BK channel proteins expression, 
and no influence on PKG expression or activity. We next examined whether LTH 
influences protein organization, which could potentially control PKG-mediated 
vasorelaxation in normoxic and hypoxic conditions. Using confocal microscopy, we 
learned that LTH strongly alters protein organization, and specifically the proximal 
association of three proteins associated with vasorelaxation, namely PKG, BK-alpha and 
BK-beta. 
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CHAPTER ONE 
INTRODUCTION 
 
Vasorelaxation 
The human body is amazingly well-engineered to survive and to adapt in response to 
a wide range of changes in environmental conditions, including temperature, available 
nutrients, ambient oxygen, and more. For example, a rapid decrease in available oxygen 
or a rise in temperature triggers an acute hemodynamic shift that favors survival of 
critical organs (brain, heart, kidneys etc.) at the expense of more hypoxia-tolerant tissues 
(skeletal muscle, adipose, etc.). This is possible because vascular tissues are richly 
invested with smooth muscle that is able to contract or relax under a well-regulated 
network of sensors and effectors. 
 
Contraction of Vascular Smooth Muscle  
Contraction of vascular smooth muscle is important for maintaining vascular tone and 
regulating peripheral vascular resistance, essential for controlling cardiac output and 
normal blood pressure.  Intrinsic effectors of vasoconstriction include angiotensin (5), 
endothelin (30), epinephrine, norepinephrine, and many more. Release of serotonin (5-
hydroxytryptamine) from platelets at the site of a tissue injury induces a powerful 
constriction of arterial smooth muscle, effective in reducing an acute loss of blood (2). At 
the cellular level, vasoconstriction is mediated by a release of calcium which is the main 
signal for activating the contractile apparatus (12). 
 
 2 
Relaxation of Vascular Smooth Muscle 
Relaxation of vascular smooth muscle is dominantly under control of vascular 
endothelium and mediated by the nitric oxide (NO) pathway (33). NO-induced 
vasorelaxation is important for enlarging vessel luminal diameter to increase blood flow 
and delivery of oxygen and nutrients in response to metabolic demand. Vascular tone is 
thus a dynamic balancing act of vasoconstriction and vasorelaxation.   
The main effector of the NO pathway is the cGMP dependent protein kinase 
(PKG) which phosphorylates a repertoire of proteins to induce vasorelaxation by 
decreasing calcium release or reducing calcium sensitivity of the contractile apparatus 
(3). However, it was observed more than a decade ago that vascular smooth muscle 
(VSM) exhibits a peculiar phenomenon:  that nitric oxide (NO) is relatively ineffective as 
a vasodilator in chronically hypoxic animals, including humans (12, 28, 46). This is a 
clinically important issue because strategies to increase oxygen perfusion during 
conditions of acute hypoxia or ischemic injury may fail in critical situations, particularly 
in individuals with a history of exposure to chronic hypoxia. The mechanisms underlying 
this loss of function are not completely understood. The foregoing investigation examines 
one aspect of this phenomenon: that is the role of cyclic GMP-dependent protein kinase 
(PKG) as a mediator of the NO signaling pathway, and its apparent loss of function 
secondary to chronic hypoxia.  
Given that literally hundreds of known cellular proteins are involved with the 
physiology of VSM contraction, the scope of this investigation has necessarily included 
multiple likely candidates to explain the loss of PKG-mediated vasorelaxation under 
hypoxic conditions. This has included each step of the NO signaling pathway, receptor 
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affinity and occupancy, changes in ion channels, and the abundance and specific activity 
of PKG itself. It appears that no single candidate protein accounts for the observed 
hypoxic attenuation of PKG-mediated vasorelaxation. Rather several proteins are 
cooperatively influential in regulating vascular tone and are sensitive to chronic hypoxia. 
In particular, the large-conductance calcium-activated potassium channel (BK) is an 
important mediator of vasorelaxation: it has several known PKG serine/threonine kinase 
targets that influence its conductance (50), and it has been shown to have a reduced 
potassium conductance under hypoxic conditions (27). The role of PKG in mediating the 
changes in the BK channel in response to chronic hypoxia is not established in cerebral 
arteries. That was the focus of this investigation.  
To identify a specific role of PKG in the hypoxia-induced shift in VSM tone, this 
study focused on the BK channel and the influence of PKG on this ion channel under 
normoxic and hypoxic conditions. The main hypothesis is that chronic hypoxia attenuates 
the ability of PKG to activate BK channels in cerebral arteries. Whereas PKG has 
previously been shown to promote vasorelaxation in normoxic ovine carotid arteries, and 
that hypoxia attenuates this phenomenon (42), this proposed study investigates the effects 
of hypoxia on the influence of PKG specifically by action on the BK channel in cerebral 
arteries. In this study 5-hydroxytryptamine (5-HT, aka serotonin) was used as a VSM 
contractant. PKG was manipulated (activated) by use of the phosphodiesterase-resistant 
8-(p-chlorophenylthio)-guanosine 3’,5’-cyclic monophosphate (aka 8pCPT-cGMP). The 
BK channel was manipulated (inhibited) by the channel-selective inhibitor iberiotoxin. 
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Vascular Smooth Muscle 
Vascular Smooth Muscle Phenotypes 
Long-term changes in the responsiveness of cerebral arteries due to maturation or 
chronic stress typically involves a change the relative mix of VSM phenotypes.  Four 
separate VSM phenotypes are recognized, which includes 1) proliferative, 2) migratory, 
3) secretory, and 4) contractile (21).  Traditionally, the contractile phenotype has been 
recognized as the mature endpoint of phenotypic progression. It is now understood that 
this is reversible; the contractile phenotype has been shown to revert to a synthetic 
phenotype under various conditions (31) including hypoxic stress or multiple passages in 
organ culture (20). This reversion is characterized by a downregulation of the expression 
of contractile genes and their respective proteins. Typically, in a given artery, and within 
a range of stressors and/or maturity, all four phenotypes are represented, albeit of varied 
proportions. 
 
Cerebral Vascular Arteries as Conduits 
In the average adult human, the brain represents about 2% of the total body 
weight. Yet despite its relatively small size, the brain consumes about 20% of the oxygen, 
and therefore total calories of the entire body (4). Equally remarkable, this high rate of 
metabolism is fairly constant despite strongly variable mental and motor activity (33). 
Cerebral arteries serve an obvious function, that of a conduit to transport oxygen, 
nutrients and signaling molecules to the brain.  Less obvious is the regulatory role in 
maintaining a delicate homeostasis between the fairly constant metabolic demand of the 
brain, and strongly variable conditions of somatic hydrostatic pressure and available 
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oxygen. Middle cerebral arteries (MCAs) are anatomically situated between the much 
larger carotid arteries, and the smaller pial resistance arteries/arterioles.  As such they 
have much in common with the carotids structurally and anatomically, and respond 
similarly to systemic influences.  Compared with carotid arteries, MCAs are an order of 
magnitude smaller diameter, have fewer layers of VSM, are invested with substantially 
less adventitial material, and are typically more compliant. Consideration of cerebral 
arteries as a passive conduit is a useful abstraction for purposes of contrasting their basic 
transport function with their dynamic adaptive properties. As arteries become less 
compliant and less responsive to stressors, due to passage of time, hypoxia or other 
pathologies, the passive transport model more closely approximates their actual function. 
 
Cerebral Vascular Arteries as Regulators of Vascular Tone 
Middle cerebral arteries are anatomically closer to the neural tissues they service, 
compared with carotids, and would be expected to be more responsive to metabolic 
demand.  But unlike the downstream pial arteries, MCAs lack direct retrograde neuronal 
connectivity that couple local oxygen demand with rapid changes in flow volume (8). 
Vasorelaxation in MCAs is largely mediated by endothelial release of NO, and is 
sensitive to pressure and flow dynamics, as well as global systemic influences (38).  By 
contrast, regulation of pial resistance arteries is dominated by an endothelial-mediated but 
neuronally-coupled sensitivity to metabolic events proximally downstream (8).  
Responses to contractile and vasorelaxant stimuli of both MCAs and pial arteries is rapid, 
typically on the order of seconds to minutes. 
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The Nitric Oxide (NO) Pathway 
Regulation of cerebral vascular circulation is very dynamic, and is driven by metabolic 
demand (27). This is accomplished in part by the “neurovascular unit”, of which the 
endothelium plays a major role (36). Oxygen perfusion in the brain is enhanced locally 
by vasorelaxation which increases the luminal volume and leads to increased transport of 
oxygen and nutrients. Vasorelaxation is likewise controlled in part by the endothelium 
which in response to a stimulus activates the NO signaling pathway (11) (Figure 1). This 
pathway is well-studied. Briefly, NO is synthesized from arginine in vascular 
endothelium by action of endothelial nitric oxide synthase (eNOS). The NO thus 
generated is freely permeable into vascular smooth muscle (VSM) and has a half-life on 
the order of a few seconds (24), which makes it an ideal paracrine signal; this effect is 
very localized. NO in turn activates soluble guanylate cyclase (sGC) which in turn 
converts guanine triphosphate (GTP) into cyclic guanine monophosphate (cGMP). The 
half-life of cGMP is variable depending on the abundance and activity of endogenous 
phosphodiesterase (PDE). Inhibition of PDE is known to enhance/prolong the effects of 
cGMP and increase vasorelaxation (28, 35). Cyclic GMP itself has multiple signaling 
receptors within VSM including prominently PKG (40), which in turn has many cellular 
kinase targets (32). The role of PKG in VSM is generally to promote vasorelaxation (29) 
by adding a phosphate group to multiple cellular proteins involved with 
contraction/relaxation, and to promote and maintain the contractile VSM phenotype in 
cerebral arteries (19).  
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Figure 1.  The Nitric oxide pathway.  In response to a stimulus, the vascular endothelium 
activates nitric oxide synthase which converts arginine to nitric oxide (NO). NO is freely 
permeable across the plasma membrane. NO diffuses into nearby vascular smooth muscle 
cells (VSMCs) where it activates soluble guanylate cyclase (sGC) which in turn converts 
guanosine triphosphate (GTP) into cyclic guanosine monophosphate (cGMP).  cGMP 
binds to the regulatory domain of cGMP-dependent protein kinase (PKG) which induces a 
conformational shift in the dimeric PKG protein that exposes its catalytic domain, which 
effectively activates its kinase activity.  Activated PKG phosphorylates a repertoire of 
proteins within the VSMC that promotes vasorelaxation. 
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Cyclic GMP-dependent Protein kinase (PKG) 
Cyclic GMP-dependent Protein kinase (PKG) is a serine/threonine kinase that is 
expressed in vascular smooth muscle (16) and has multiple target proteins (32). PKG-I 
exists in two alternately spliced isoforms PKG-Iα and PKG-Iβ. PKG-Iα is 10-fold more 
sensitive to activation by cGMP compared with PKG-Iβ (41). PKG has three functional 
domains: 1) N-terminal domain has a protein recognition/docking and auto-inhibitory 
domain, 2) a regulatory domain that binds to cGMP, and 3) a catalytic domain that 
includes a substrate recognition motif (26). Monomeric PKG is auto-inhibited by its N-
terminal tail which effectively occupies/occludes the catalytic domain. Dimerization of 
PKG displaces the auto-inhibitory tail and exposes the two cGMP regulatory domains. 
Binding of cGMP induces a conformational change in PKG that allows recognition and 
binding to its substrate and activation of its serine/threonine kinase domain. This process 
is dynamic and reversible. PKG itself is subject to activation by V-src, a cellular tyrosine 
kinase (16). Activity of cGMP-activated PKG is elevated 4-fold when phosphorylated by 
V-src. PKG is sensitized to cGMP by action of calcium-activated protein kinase (PKC) 
on PKG Threonine T58, although this phosphorylation is not alone sufficient to activate 
PKG (10). These suggest multiple regulatory opportunities for activation and 
sensitization of PKG. However, this investigation has shown that changes in specific 
activity of PKG under hypoxic versus normoxic conditions is not significant in middle 
cerebral arteries. 
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PKG Activates Proteins That Regulate Vascular Tone 
Monomeric PKG is ubiquitous in vascular smooth muscle. It is freely soluble in 
the cytoplasm, but could be described as “sticky” when activated by cGMP. That is, 
binding of cGMP to the regulatory domain of PKG exposes its protein recognition 
domain, that causes it to rapidly (trans) autosphorylate and dimerize into its 
enzymatically active configuration.  PKG then effectively associates with its kinase 
substrate proteins (1, 3).  PKG substrates that affect vascular tone include the BK channel 
alpha subunit (which promotes hyperpolarization of the VSM), myosin light chain 
phosphatase (which de-activates MLC20-induced VSM contraction) (44), and many more 
(32). 
 
PKG and its Downstream Effectors Are Implicated in Hypoxia-Associated Loss 
of Vasorelaxation 
Earlier studies have shown that the NO pathway mediates vasorelaxation and that 
hypoxia diminishes the effectiveness of this pathway (42). These investigations have 
established that 1) endothelial eNOS abundance and specific activity remain largely 
unaffected by chronic hypoxia, 2) sGC abundance and specific activity are likewise 
mostly unaffected and 3) intracellular cGMP levels increase due to a hypoxia-mediated 
suppression of PDE (28). This seeming paradox, the loss of vasorelaxation accompanied 
by an increase in cGMP, resolves when it is regarded that the depression of PDE 
represents an incomplete attempt to compensate for hypoxia-related stress in a feed-
forward paradigm. This immediately implicates PKG and its downstream mediators as 
having a mechanistic role in the hypoxia-mediated loss of vasorelaxation. This 
investigation has demonstrated that in carotid and middle cerebral arteries, the abundance 
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and specific activity of PKG is only moderately affected by chronic hypoxia. This places 
the focus directly on PKG substrates, their abundance and localization, and their 
susceptibility to phosphorylation by PKG. Prominent among these is the BK channel, 
which is a known PKG substrate that plays a major role in VSM relaxation. This 
investigation has thus focused on the role of PKG and the BK channel proteins. 
 
The BK Channel 
The BK (big potassium) channel is bound to the plasma membrane in VSM and 
selectively conducts K+ ions outwardly. It consists of a homotetramer of four ~125 kDa 
alpha proteins, and associates with anywhere from zero to four beta subunits which serve 
to stabilize and regulate the BK channel activity (25) and increase its calcium sensitivity 
(17). Conductance of K+ is controlled mostly by intracellular [Ca2+], but is also voltage- 
and stretch-sensitive (7, 34). Calcium sensitivity is conferred by the intracellular C-
terminal RCK (Regulator of Conductance of K+) domain which contains four Ca2+ 
binding motifs (the “calcium bowl”), which upon association with Ca2+ confers a shift in 
its structural conformation that increases its “open” probability (Po) by several fold. PKG 
has been shown to influence BK channel Ca2+ sensitivity (18). There are several 
serine/threonine PKG targets within the C-terminal domain that affect channel Ca2+ 
sensitivity (45, 46), (15). The regulation of BK channel sensitivity by PKG is complex 
and involves a concomitant influence of PKA and PKC serine/threonine targets near the 
PKG phosphorylation site (45). These affect the ability of PKG to up-regulate BK 
channel conductance. The role of hypoxia in this process is not well understood. It is a 
premise of this investigation that hypoxia may influence target proteins rather than 
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altering PKG itself, which would thereby alter the ability of PKG to promote 
vasorelaxation. Hypoxia-driven alterations in the phospho-status of the BK channel 
proteins or their local distribution would conceivably alter the ability of PKG to interact 
with these proteins. Given that the BK channel has a dominant role in promoting 
vasorelaxation (6), it is of interest to know the relative influence of BK- versus non-BK 
effects on vasorelaxation. One arm of this study partitioned these effects, expressed as a 
fraction. It is also apparent that the sheer abundance and distribution of the BK channel 
proteins could potentially determine BK channel activity. Recent studies suggest that the 
abundance and localization of the beta-1 subunit is a major determinant of BK channel 
activity in some tissues (17). This investigation measured the abundance of BK channel 
alpha and beta proteins in cerebral arteries by Western blotting. Colocalization of alpha 
with beta subunits was measured by confocal microscopy. 
 
 
Protocols 
Protocol 1 - Functional:  Contractile Force  
The first protocol measures contractile force as a functional outcome in each of 
the eight experimental groups. This is accomplished by suspending artery segments in an 
isotonic Krebs solution and measuring force using an isometric force transducer. 5-HT is 
used as a contractant and the resultant force is normalized as a percentage of the 
maximum K+ induced contraction. Artery segments were either 1) untreated (control), 2) 
treated with 30 μM 8-pCPT-cGMP, 3) 100 nM iberiotoxin, or 4) both 8-pCPT and 
iberiotoxin. The independent effects of hypoxia and age/maturity is directly calculated 
using an algebraic model.  
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Protocol 2 - Structural:  Abundance of BK Channel Proteins 
The second protocol uses Western blotting to measure the structural abundance 
of the two main BK channel proteins, BK-I alpha and BK-beta1 in cerebral arteries. 
Three other forms of BK-beta exist; beta1 is the primary subunit that stabilizes and 
modulates the BK-I alpha subunit in VSM, although minor expression of beta-2 and beta-
4 are reportedly present in cerebral arteries (22). The mechanisms whereby chronic 
hypoxia is able to influence BK channel activity are not well understood, but includes 
alternate splicing (STREX vs. ZERO isoforms (39), (37)), and may involve RNA editing, 
transcription, translation and cellular trafficking. The sheer abundance of the BK-alpha 
subunit perhaps represents an upper limit on the functional capacity of the BK ion 
channel. Given the recent understanding of the role of the BK-beta1 subunit to regulate 
and modify BK channel activity (17), the abundance of this protein is of high interest. As 
many as zero to four BK-beta1 subunits are known to associate with the BK-alpha 
tetramer. A strict stoichiometry between alpha and beta subunits is not essential for 
channel conductance; but a higher ratio of beta to alpha subunits in the membrane 
complex correlates with increased calcium sensitivity and channel activity (43). Thus the 
ratio of the two BK subunit types is also of interest. Western blotting is considered to be 
semi-quantitative (9, 13, 14, 23), but is sufficient to address the experimental question, 
especially since it is the relative differences in protein abundance and ratios that are of 
interest.  
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Protocol 3 - Relational:  Colocalization of PKG with Channel Proteins  
The third protocol examines cellular protein-protein relationships by use of 
confocal microscopy using dual fluorescent-labeled markers. The purpose for this was to 
correlate structural and functional relationships that cannot be explained by mere 
abundance of PKG or its substrates. Independently, each of the three possible pairs of 
these three proteins were imaged, then analyzed using Colocalizer Pro® to quantify the 
degree of colocalization. Additionally, these same images were further analyzed by 
calculation of a protein proximity index,  
Taken together, these three protocols represent a functional, structural, and 
relational measure to quantify the effect of chronic hypoxia on the ability of PKG to 
influence BK channel activity in fetal and adult cerebral arteries. Each protocol of this 
investigation is represented graphically in Figure 2.  
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Figure 2.  Experimental design.  Each aim of this investigation is represented by each 
corresponding protocol.  Aim 1 examines a measurable functional endpoint, contractile 
force under conditions of normoxia and hypoxia, and in fetal and adult arteries. Aim 2 
examines the structural abundance of key proteins, PKG and BK channel alpha and beta 
isoforms using Western blotting analysis. Aim 3 examines the structural relationships of 
these same proteins, using confocal microscopy the measure colocalization. 
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The Purpose for this Study 
The main hypothesis of this study is that chronic hypoxia alters the ability of 
PKG to influence the BK potassium channel and thereby diminishes its ability to 
induce vasorelaxation in cerebral arteries. Given that PKG is pleiotropic and has multiple 
target proteins, many of which are involved with regulation of vascular tone, it was 
necessary to separately identify the BK- versus the non-BK influences of PKG under 
hypoxic and normoxic conditions. To accomplish this, the BK channel was selectively 
inhibited by use of iberiotoxin. Effects attributable to the BK channel therefore appeared 
as functional differences between inhibited and uninhibited arteries. Non-BK channel 
effects of PKG are also subject to the influence of chronic hypoxia, which was likewise 
measured in BK-inhibited normoxic and hypoxic arteries. Each of the experiments was 
performed in both fetal and adult cerebral arteries. This defines three orthogonally 
independent axes: 1) BK vs. non-BK, 2) hypoxic vs. normoxic, and 3) fetal vs. adult; and 
thus eight separate experimental groups.  
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CHAPTER TWO 
HYPOXIC DEPRESSION OF PKG-MEDIATED INHIBITION OF 
SEROTONERGIC CONTRACTION 
IN OVINE CAROTID ARTERIES 
 
Abstract 
Chronic hypoxia attenuates soluble guanylate cyclase-induced vasorelaxation in 
serotonin (5-HT)-contracted ovine carotid arteries. Because protein kinase G (PKG) 
mediates many effects of soluble guanylate cyclase activation through phosphorylation of 
multiple kinase targets in vascular smooth muscle, we tested the hypothesis that chronic 
hypoxia reduces the ability of PKG to phosphorylate its target proteins, which attenuates 
the ability of PKG to induce vasorelaxation. We also tested the hypothesis that hypoxia 
attenuates PKG expression and/or activity.  Arteries from normoxic and chronically 
hypoxic (altitude of 3,820 m for 110 days) fetal and adult sheep were denuded of 
endothelium and equilibrated with 95% O2-5% CO2 in the presence of nitro-L-arginine 
methyl ester (L-NAME) and NG-nitro-L-arginine (L-NNA) to inhibit residual endothelial 
nitric oxide synthase. Concentration-response relations for 5-HT were determined in the 
presence of prazosin to minimize activation of α-adrenergic receptors. The PKG activator 
8-(p-chlorophenylthio) guanosine 3’,5’-cyclic monophosphate (8-pCTP-cGMP) reduced 
agonist binding affinity of the 5-HT receptor in a concentration-dependent manner that 
was attenuated by hypoxia.  Expression and activity of PKG-I was not significantly 
affected by chronic hypoxia in either fetal or adult arteries, although PKG-I abundance 
was greater in fetal arteries. Pretreatment with the large conductance calcium-sensitive 
potassium channel (BK) inhibitor iberiotoxin attenuated the vasorelaxation induced by 8-
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pCPT-cGMP in normoxic but not chronically hypoxic arteries. These results support the 
hypothesis that hypoxia attenuates the vasorelaxant effects of PKG through suppression 
of the ability of PKG to activate large conductance calcium-sensitive potassium channels 
in arterial smooth muscle. The results also reveal that this hypoxic effect is greater in 
fetal than adult arteries and that chronic maternal hypoxia can profoundly affect fetal 
vascular function. 
 
Introduction 
Chronic hypoxia is a common stressor in many clinical pathologies and is 
particularly devastating during pregnancy (17, 28).  Maternal hypoxia induces a broad 
variety of effects in both mother and fetus, including numerous changes in vascular 
structure and function (26, 46). Prominent among these functional changes is a depressed 
capacity for vasorelaxation evident in both the pulmonary (50) and systemic (33) 
circulations.  These effects are explained in part by hypoxic depression of endothelial 
nitric oxide (NO) release (35) and efficacy (45). In turn, chronic hypoxia also modestly 
depresses the ability of NO to activate soluble guanylate cyclase and stimulate the 
synthesis of cGMP (9, 46). More importantly, chronic hypoxia can attenuate the ability of 
cGMP to promote vasorelaxation in multiple vascular beds (36). 
For vasorelaxation, the primary target of cGMP is cGMP-dependent protein kinase 
(PKG), a serine-threonine kinase expressed as two isoforms (Iα and Iβ) in mammalian 
vascular smooth muscle (47). When bound to cGMP both isoforms of PKG are 
enzymatically active as homodimers that phosphorylate serine-threonine residues in a 
broad variety of target proteins (2, 7, 39).  At the plasmalemma, PKG can phosphorylate 
 22 
the α-subunit of the large conductance calcium-sensitive potassium (BK) channel and 
thereby increase its sensitivity to cytosolic Ca2+ and its opening probability (38, 40). 
PKG-mediated phosphorylation also activates plasma membrane Ca2+-ATPase (48) and 
inhibits the plasmalemmal L-type calcium channel (16); both of these effects reduce 
cytosolic Ca2+ concentration and promote vasorelaxation. Inside the smooth muscle cell, 
PKG-mediated phosphorylation can stimulate the sarco(endo)plasmic reticulum Ca2+-
ATPase (SERCA) calcium pump (8) and attenuate sarcoplasmic reticulum (SR) Ca2+ 
release through the inositol 1,4,5-trisphosphate (IP3) receptor (19). PKG-mediated 
phosphorylation of transcription factors such as cAMP response element binding protein 
(CREB) and serum response factor (SRF) influence transcription of multiple genes 
involved in regulation of smooth muscle phenotype (6, 37). 
Our main hypothesis is that chronic hypoxia alters the capacity for PKG-mediated 
vasorelaxation through direct effects on PKG and/or the proteins it phosphorylates. To 
test this hypothesis, we examined the effects of chronic hypoxia on PKG abundance and 
activity in ovine carotid arteries (20).  Because effects of chronic hypoxia differ in fetal 
and adult arteries (45), we examined both fetal and adult carotid arteries using a model 
designed to assess the effects of maternal hypoxia on fetal oxygenation. This model is 
clinically relevant to fetal hypoxemia resulting from placental insufficiency, maternal 
smoking, maternal pulmonary insufficiency, etc. (26). To minimize confounding effects 
of endothelial and extravascular stimulation of PKG, the vascular endothelium was 
mechanically removed, any residual endothelial NO synthase was inhibited, and 
adrenergic receptors were selectively antagonized so that the results uniquely represent 
the effects of PKG in smooth muscle pharmacomechanical coupling following hypoxic 
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acclimatization. In an effort to identify the categories of protein targets whose 
phosphorylation by PKG may change with hypoxia, we compared multiple endpoints 
between normoxic and hypoxic arteries. These endpoints included the ability of PKG to 
attenuate 5-HT-induced contractile force, to alter agonist affinity, and to influence BK 
channel function.  Serotonin was used as the contractile agonist in these experiments 
owing to its ubiquitous potency (43), well-characterized endothelium-independent 5-
HT2A receptor-mediated mechanism of contraction (42), and the potential for regulation 
of the binding affinity of this receptor by phosphorylation (1). The BK channel was 
specifically examined because of its role in membrane potential homeostasis, high K+ 
currents, Ca2+ sensitivity, and known PKG phosphorylation sites. Together, these 
experiments provided a unique insight into the age-dependent effects of chronic hypoxia 
on PKG function in vascular smooth muscle. 
  
Materials and Methods 
All procedures in this study were approved by the animal Research Committee of 
Loma Linda University and adhere strictly to the policies and practices according to the 
National Institutes of Health Guide governing the care and use of laboratory animals. 
 
Tissue Harvest and Preparation 
All common carotid arteries used in this study were harvested using sterile 
techniques from normoxic and chronically hypoxic fetal (139–142 days’ gestation) and 
young (18–24 mo. old) nulliparous adult sheep. In normoxic animals maintained at sea 
level arterial oxygen tensions (PaO2) averaged 23 ± 1 and 102 ± 2 Torr in fetal and adult 
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sheep, respectively (18). Corresponding arterial blood pressures averaged 44 ± 2 and 81 ± 
3 mmHg, respectively. Chronically hypoxic sheep were maintained for ~110 days at high 
altitude (altitude 3,820 m, Barcroft Laboratory, White Mountain Research Station, 
Bishop, CA). For pregnant ewes, the period at altitude corresponded to the final 110 days 
of gestation, where term averages 143 days. At altitude, fetal and adult PaO2 values 
averaged 19 ± 1 and 64 ± 2 Torr, respectively. Corresponding blood pressures in these 
animals averaged 52 ± 1 and 88 ± 4 mmHg, respectively.  Pregnant ewes were 
anesthetized with 30 mg/kg pentobarbital, intubated, and then placed on 1.5–2.0% 
halothane. The anesthetized fetus was then exteriorized through a midline vertical 
laparotomy and euthanized by rapid removal of the heart and exsanguination. Non-
pregnant adult animals were euthanized by intravenous administration of 100 mg/kg 
pentobarbital. Harvested carotid arteries were placed in Krebs buffer solution containing 
(in mM) 122 NaCl, 25.6 NaHCO3, 5.17 KCl, 2.49 MgSO4, 1.60 CaCl2, 2.56 dextrose, 
0.027 EGTA, and 0.114 ascorbic acid, bubbled with 95% O2-5% CO2. Arteries were 
debrided of loose extracellular and connective tissue and then denuded of endothelium by 
passage of a stainless steel rod through the lumen. The vascular endothelium was 
systematically removed to minimize the potentially confounding effects of endothelial 
NO release on cGMP synthesis and PKG activation. 
 
Determination of Concentration-Response Relations for 5-HT 
Denuded carotid arteries were cut into segments 1 mm to 2 mm in length, mounted 
on tungsten wire loops, and suspended from a force transducer in a sodium-replete Krebs 
buffer solution (pH 7.4) at 38°C (the ovine core temperature) and bubbled with 95% O2 
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and 5% CO2. To inhibit endogenous nitric oxide (NO) production, 10 μM nitro-
L-arginine methyl ester (L-NAME) and 10 μM NG-nitro-L-arginine (L-NNA) were 
added to the Krebs buffer solution. To selectively inhibit activation of α1-adrenergic 
receptors by 5-HT, 1.0 μM prazosin and 0.2 μM cocaine were added. In preliminary 
experiments, both endothelium-intact and endothelium-denuded segments were studied.  
Because endothelium removal had no effect on average contractile efficacy, but reduced 
its variability, all further experiments were performed in endothelium-denuded segments. 
The denuded segments were equilibrated for 30 min and then stretched to a baseline 
tension of 1.5 g, which corresponds with an optimal stretch ratio of ~1.8 times the 
unstressed diameter.  Contractile force was measured directly using an isometric force 
transducer (Kent Scientific, Torrington, CT) and recorded directly by computer. 
Concentration-response curves were obtained by cumulative addition of half-log 
concentrations of 5-HT across a range of 10-10 to 10-4 M. In preliminary experiments, 
norepinephrine was also used as the contractile agonist, but it was significantly less 
potent and less efficacious than serotonin in producing contractions; all further 
experiments were performed using 5-HT.  EC50 values (molar concentration at which the 
contractile response was half the maximal induced contraction) were expressed as pD2 
values (-logEC50). All contractile responses were normalized to the maximum force 
produced by exposure to a potassium-Krebs solution containing (in mM) 5.17 NaCl, 25.6 
NaHCO3, 122 KCl, 2.49 MgSO4, 1.60 CaCl2, 2.56 dextrose, and 0.027 EGTA.  To test 
the contribution of large conductance calcium-sensitive potassium (BK) channels to 5-HT 
contractions, concentration-response experiments were also carried out in the presence of 
the selective BK channel blocker iberiotoxin at a concentration of 100 nM (dissolved in 
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Krebs), a concentration that previous work has shown to be optimal (41). Iberiotoxin was 
added to the baths, in both the presence and absence of 30 μM 
(4-chlorophenylthio)guanosine-3’,5’-cyclic monophosphate (8-pCPT-cGMP), 30 min 
before commencement of the concentration-response sequences.   
 
Measurement of Agonist Binding Affinity and Receptor Occupancy 
The 5-HT-receptor dissociation constants were determined via the Furchgott 
method of partial irreversible blockade (13) with the alkylating agent phenoxybenzamine 
(50–150 nM), as originally described in detail by our laboratory (15, 42). Briefly, pairs of 
artery segments were untreated or pretreated with the PKG activator 8-pCPT-cGMP 
across a range of concentrations from 0 to 30 μM to determine the influence of PKG. The 
final concentration of phenoxybenzamine used in each artery was chosen to achieve a 
50% decrease in 5-HT efficacy with 30 min incubation, followed by a washout. Pairs of 
adjacent phenoxybenzamine-treated and -untreated artery segments were then assayed to 
obtain concentration-response curves across a range of 10-10 to 10-4 M 5-HT.  Equiactive 
concentrations of 5-HT in treated [A’] and untreated [A] arteries were plotted as a double 
reciprocal plot of 1/[A] versus 1/[A’] from which the regression line was calculated; the 
dissociation constant was taken as the ratio Ka = slope – (1/intercept). Using the apparent 
Ka for the 5-HT2A receptor complex, fractional receptor occupancy was calculated from 
the equation: [RA]/[RT] = [A]/([A] + Ka), where [RA] was the concentration of the 
receptor-agonist complex, and [RT] was the total receptor concentration (31).  
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Western Blot Analysis of PKG Abundance 
Common carotid artery segments were homogenized using glass-on-glass mortars 
and pestles in 50 mM HEPES (pH 7.4), 2 mM magnesium acetate, 2 mM DTT, 1 mM 
EDTA, 520 μM AEBSF, 7.5 μM pepstatin-A, 7 μM E-64, 20 μM bestatin, 100 μM 
leupeptin, and 0.4 μM aprotinin. Supernatants were collected after centrifugation at 
100,000 g for 1h at 4°C and analyzed for protein content using the Bradford assay, as 
described previously (4, 34), and then divided for separate analysis of PKG abundance by 
Western blot and PKG activity. Samples for PKG abundance were separated by SDS-
PAGE and then transferred to nitrocellulose membranes for immunodetection. Primary 
antibodies for total PKG were obtained from Stressgen (1:1,000; catalog no.  KAS-
PK005). This antibody detected a PKG-I epitope common to both the α- and β-isoforms. 
Blots were visualized using the chemiluminescent substrate Supersignal West Dura 
(catalog no. 37071, Thermo Scientific), and images were then captured on an Alpha 
Innotech Fluorchem (Cell Biosciences, Santa Clara, CA).  Relative abundances of total 
PKG were normalized to standards prepared from arteries harvested from adult normoxic 
non-pregnant ewes. 
 
Measurement of PKG-I Activity 
Samples of supernatants from the homogenates prepared for measurements of PKG 
abundance (described in Western blot analysis of PKG abundance) were cleared for 30 
min at 30°C after which 5 mM NaF and 1 μM PKI (a PKA inhibitor, Sigma-Aldrich 
P6061) were added. After 30 min of incubation, sample aliquots were added to reaction 
buffer in 96-well plates to yield final concentrations of 200 μM ATP with 300–400 
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cpm/pmol [λ-32P]ATP (NEN), 200 μM PKG substrate BPDEtide (BMLP112-0001, Enzo 
Life Sciences), and 10 μM 8-pCPT-cGMP (Sigma-Aldrich, C5438) in homogenizing 
buffer. Timed reactions were terminated by addition of phosphoric acid. Phosphorylated 
BPDEtide and unreacted [λ-32P]ATP were separated through phosphocellulose paper 
using a Millipore 96-well filtration plate. Filters were washed with phosphoric acid, 
allowed to dry, added to vials with scintillation cocktail, and assayed using a λ-
scintillation counter. Counts were converted into moles 32P using a calibration curve 
counted in parallel with the samples and normalized to sample protein content to obtain 
activity in units of pmol 32P transferred per minute per milligram of protein. Each assay 
included blanks with: 1) no added 8-pCPT-cGMP; 2) no added BPDEtide substrate; and 
3) neither 8-pCPT-cGMP nor BPDEtide to enable correction for total nonspecific 
background. 
 
Data Analysis and Statistics 
Significant differences in contractile variables were determined using Behrens-
Fischer tests for two-group comparisons and ANOVA followed by Duncan’s post hoc 
simultaneous comparisons of more than two groups. Analyses using the SPSS software 
routinely confirmed homogeneity of variance and normal data distributions (SPSS v19). 
Determinations of pKa values were based on double reciprocal plots from which slopes 
were determined by linear regression as described by Furchgott (13, 31). Contractile 
forces were normalized relative to the contraction as measured upon exposure to isotonic 
120 mM potassium-Krebs in the same artery segment. The relative influence of PKG 
stimulation on the BK potassium channel compared with all other downstream targets 
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was estimated with an algebraic model where a = maximum response to 5-HT in control 
arteries (untreated), b = total maximum response to 5-HT in the presence of PKG 
stimulation by 8-pCPT-cGMP, c = maximum response to 5-HT in presence of 
iberiotoxin, and d = maximum response to 5-HT in the presence of iberiotoxin and with 
pretreatment using 8-pCPT-cGMP. The total effect of PKG activation was defined as 
(a - b), and the effect of PKG activation independent of BK channel activity was defined 
as (c - d). The BK channel-dependent effect of PKG activation was calculated as 
(a - b) - (c - d). Maximum efficacy of 5-HT was calculated using SPSS (version 19) with 
a nonlinear regression model using the four-parameter Hill equation y = (e + [(f - e)/{1 + 
10^[([agonist] - g) x h]}]), where “e” represents the calculated Emax. 
 
Results 
A total of 57 sheep were used in this study of which 27 were term fetal lambs and 
30 were adult sheep. From these animals we harvested a total of 233 carotid artery 
segments, including 113 fetal segments and 120 adult segments. Throughout the text, “n” 
represents the number of animals, and not the number of segments used in each 
experiment. Unless stated otherwise, statistical significance implies P < 0.05. All values 
are given as means ± SE.  
 
Effects of Hypoxia, Age, and 8-pCPT-cGMP on 5-HT Concentration-Response 
Relations 
Maturation significantly reduced maximal responses to 5-HT (efficacy) in 
normoxic animals (Fig. 1, left). Chronic hypoxia increased maximal responses to 5-HT in 
 30 
both fetal and adult arteries and eliminated age-related differences in efficacy (Fig. 1, 
right). Pretreatment with 8-pCPT-cGMP, a cell-permeant and phosphodiesterase-resistant 
PKG activator, significantly attenuated 5-HT efficacy in normoxic fetal and adult arteries 
in a concentration-dependent manner. In hypoxic arteries, 8-pCPT-cGMP had no 
significant effects on 5-HT efficacy at any of the concentrations tested. The effects of 8-
pCPT-cGMP on 5-HT efficacy were similar in endothelium-intact fetal (control: 131 ± 7; 
8-pCPTcGMP: 123 ± 5) and endothelium-denuded fetal (control: 138 ± 5; 8-pCPT-
cGMP: 129 ± 5) artery pairs (n = 7).  Similarly the effects of 8-pCPT-cGMP on 5-HT 
efficacy were the approximately the same in endothelium-intact adult (control: 126 ± 9; 
8-pCPT-cGMP: 110 ± 16) and endothelium-denuded adult (control: 133 ± 4; 8-pCPT-
cGMP: 124 ± 3) artery pairs (n ± 5).  
 
Effects of Hypoxia, Age, and 8-pCPT-cGMP on 5-HT Agonist Potency and 
Binding Affinity 
Values for 5-HT potency (pD2 = -log of EC50) were significantly greater in fetal 
(6.5 ± 0.2, n ± 7) than adult (5.5 ± 0.3, n = 6) normoxic arteries (Fig. 2, top). Potency 
values were not significantly different in normoxic and hypoxic arteries for either age 
group. Pretreatment with 8-pCPT-cGMP attenuated 5-HT potency in normoxic fetal 
arteries only at 30 μM and was without effect in normoxic adult arteries at any 
concentration tested. Pretreatment with 8-pCPT-cGMP attenuated 5-HT potency at 10 
and 30 μM in hypoxic fetal arteries and at 3, 10, and 30 μM in hypoxic adult arteries. 
Chronic hypoxia significantly enhanced the depressant effects of 8-pCPT-cGMP on 5-HT 
potency.  Values for 5-HT binding affinity (pKa) were significantly greater in fetal (6.14 
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± 0.48, n = 7) than adult (5.49 ± 0.27, n = 6) normoxic arteries (Fig. 2, bottom). Binding 
affinity values were not significantly different in normoxic and hypoxia arteries for either 
age group. Pretreatment with 8-pCPT-cGMP attenuated pKa values at 10 and 30 μM in 
both fetal and adult normoxic arteries. Pretreatment with 8-pCPT-cGMP attenuated pKa 
values only at 30 μM in hypoxic adult arteries and was without effect in hypoxic fetal 
arteries. Chronic hypoxia significantly attenuated the depressant effects of 8-pCPT cGMP 
on 5-HT binding affinity. 
 
Effects of Hypoxia, Age, and 8-pCPT-cGMP on 5-HT Occupancy-Response 
Relations 
To correct for group differences in 5-HT binding affinity, the concentration-
response relations were converted to occupancy-response relations using the Furchgott 
method (13). This correction altered the shapes of the concentration-response relations 
but still revealed a significant depressant effect of 8-pCPT-cGMP on occupancy-response 
relations in both fetal and adult normoxic arteries (Fig. 3, left). Equally important, this 
depressant effect of 8-pCPT-cGMP on occupancy-response relations was not evident in 
either fetal or adult hypoxic arteries (Fig. 3, right). These results revealed that 8-pCPT-
cGMP attenuated 5-HTinduced contractility at a step downstream from ligand-receptor 
binding and that this effect of 8-pCPT-cGMP was absent in chronically hypoxic fetal and 
adult arteries. 
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Effects of Hypoxia, Age, and 8-pCPT-cGMP on PKG Abundance and Specific 
Activity 
When expressed relative to abundances in normoxic adult carotid arteries, the 
relative abundance of total PKG was significantly greater in fetal compared with adult 
arteries in both normoxic and hypoxic groups (Fig. 4).  In tissue homogenates, total PKG 
activity was significantly greater in fetal than adult arteries at 5.5 and 8.0 min of reaction 
in normoxic than in hypoxic homogenates for either age group.  When total PKG activity 
was normalized relative to total PKG abundance to estimate specific activity, the 
resulting values were similar in all groups (Fig. 5, inset). 
 
Interactive Effects of 8-pCPT-cGMP and Iberiotoxin on 5-HT-Induced 
Contraction 
In all arteries, the magnitude of decrease in 5-HT efficacy produced by 8-pCPT-
cGMP was significant in both the presence and absence of iberiotoxin, although the 
magnitudes of these effects varied considerably with both age (Fig. 6, top vs. bottom) and 
hypoxia (Fig. 6, left vs. right). Iberiotoxin attenuated the magnitude of 5-HTinduced 
contraction in all arteries, indicating a strong BK channel influence on vasorelaxation. 
Analysis of these results with our algebraic model quantified the relative contributions of 
BK-dependent and BK-independent components of PKG action on 5-HT efficacy. In both 
fetal and adult arteries, the total magnitude of PKG-mediated inhibition of 5-HT efficacy 
was reduced by hypoxia, and the BK-dependent component was virtually eliminated (Fig. 
7). In contrast, the BK-independent component of PKG-mediated inhibition of 5-HT 
efficacy was unchanged by hypoxia in both age groups. 
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Figure 1.  Effects of 8-(p-chlorophenylthio)-guanosine 3’,5’-cyclic monophosphate (8-
pCPT-cGMP) and hypoxia on 5-HT concentration-response relations. Maximum 
contractile responses to graded concentrations of 5-HT did not vary significantly with 
either age or hypoxia in untreated arteries (0 μM 8-pCPTcGMP). Pretreatment with 8-
pCPT-cGMP attenuated 5-HT efficacy in a concentration-dependent manner but only in 
normoxic arteries. *Significantly (P < 0.05) less than corresponding untreated controls. In 
arteries pretreated with 30 μM 8-pCPTcGMP, 5-HT efficacy was greater in hypoxic than 
normoxic arteries for both the fetus and adult. §Hypoxic values significantly different (P < 
0.05) than equivalently treated normoxic values in corresponding age groups. Error bars 
indicate means ± SE for n ≥ 6 for all groups.  
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Fig. 2. Effects of 8-pCPT-cGMP and hypoxia on agonist affinity and potency for 5-HT. In 
untreated control arteries (0 μM 8-pCPT-cGMP), agonist potencies (pD2 = -log EC50) were 
significantly greater in fetal than adult arteries for both normoxic and hypoxic groups. 
Normoxic (top left) and hypoxic (top right) potencies in untreated controls were not 
significantly different in either fetal or adult arteries. Treatment with 8-pCPTcGMP 
significantly depressed pD2 in normoxic fetal arteries at 30 μM (top left), in hypoxic fetal 
arteries at 10 and 30 μM (top right), and in hypoxic adult arteries at all concentrations (top 
right). In untreated control arteries, agonist affinity (pKa) was significantly greater in fetal 
than adult arteries for both normoxic and hypoxic groups (bottom left and right). Normoxic 
(bottom left) and hypoxic (bottom right) affinities in untreated controls were not 
significantly different in either fetal or adult arteries. Treatment with 8-pCPT-cGMP 
significantly depressed pKa in normoxic fetal and adult arteries at 10 and 30 μM and also 
in hypoxic adult arteries at 30 μM. §Significant differences (P < 0.05) between untreated 
control fetal and adult arteries. *Values significantly different (P < 0.05) from 
corresponding untreated controls. Error bars indicate means ± SE for n ≥ 6 for all groups.  
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Fig. 3. Effects of 8-pCPT-cGMP and hypoxia on occupancy-response relations for 5-
HT. The 5-HT concentration-response relations shown in Fig. 1 were converted to 
occupancy-response relations using values of affinity (pKa) shown in Fig. 2 to correct for 
differences in agonist binding affinity. The resulting occupancy-response relations 
revealed that compared with untreated control arteries, pretreatment with 30 μM 8-pCPT-
cGMP significantly reduced maximum efficacy for 5-HT in normoxic (left) but not hypoxic 
(right) arteries from both age groups. *Significant differences (P < 0.05, repeated measures 
ANOVA) between untreated (0 μM 8-pCPT-cGMP) and treated (30 μM 8-pCPT-cGMP) 
arteries. Error bars indicate means ± SE for n ≥ 6 for all groups. 
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Fig. 4.  Effects of hypoxia on the abundance of protein kinase G (PKG) isoforms. The 
abundance of total PKG was determined by Western blot analysis using an antibody against 
a PKG-I epitope common to both the α and β isoforms. All abundances were calculated 
relative to known amounts of a standard pool prepared from normoxic adult arteries. 
*Relative abundance of total PKG was significantly greater in fetal than adult arteries and 
was not affected by hypoxia. Error bars indicate means ± SE for n ≥ 6. 
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Figure 5. Effects of hypoxia on PKG activity. Using a peptide substrate derived from 
bovine phosphodiesterase (abbreviated as BPDE in the figure), whole artery PKG activity 
(line graph, nmol 32P-labeled BPDE/ relative unit PKG) was not significantly affected by 
hypoxia in either fetal or adult homogenates. Total PKG activity was greater in fetal 
compared with adult artery tissue homogenates, which reflects the modestly greater total 
PKG abundance in fetal arteries. When whole artery PKG activity was normalized relative 
to PKG abundance (Fig. 4), estimates of specific activity (inset, nmol 32P-labeled 
BPDE/min/relative unit PKG) did not vary significantly with hypoxia. Error bars indicate 
means ± SE for n ≥ 5.  
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Fig. 6. Interactive effects of 8-pCPT-cGMP and iberiotoxin on 5-HT concentration-
response relations. The relative contributions of PKG and BK channels to contractile 
responses to 5-HT were identified by addition of 30 μM 8-pCPT-cGMP, a PKG activator 
(▼), 100 nM iberiotoxin, a BK channel blocker (), or both (♦), respectively, in matched 
sets of adjacent segments from the same artery. §Total effect of PKG activation on 5-HT 
contraction was defined as the difference in maximum response between control and 8-
pCPT-cGMP-treated arteries. *Effect of PKG activation independent of BK channels was 
defined as the difference in maximum response between arteries treated with iberiotoxin 
alone and both iberiotoxin and 8-pCPT-cGMP. Error bars indicate means ± SE for n ≥ 8. 
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Figure 7. Estimates of the relative magnitudes of BK-dependent and BK-independent 
components of PKG activation on 5-HT-induced contractions. The total effects of PKG 
activation on the maximum contractile response to 5-HT were partitioned into BK-
independent and BK-dependent components via calculation of differences in efficacy as 
defined in Fig. 6. Hypoxia virtually eliminated the BK-dependent component of PKG-
mediated inhibition of 5-HT efficacy in both fetal and adult arteries. *Hypoxia attenuated 
total magnitude of effect of PKG on contractility in both fetal and adult arteries but had no 
significant effect on the BK-independent component. §All components of the PKG effect 
were significantly greater than zero except for the BK-dependent component in hypoxic 
arteries. Error bars indicate means ± SE for n ≥ 6.   
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Discussion 
This study of the effects of chronic hypoxia on the vasorelaxant efficacy of PKG 
in endothelium-denuded and NO synthase-inhibited arteries offers five main 
observations: 1) the ability of PKG to attenuate 5-HT-induced contractions was 
dramatically reduced in hypoxic compared with normoxic arteries, and this effect was 
greater in adult than fetal carotids; 2) PKG activation attenuated ligand binding affinity 
for 5-HT, and this effect was significantly reduced by chronic hypoxia in both fetal and 
adult arteries; 3) receptor occupancy-response relations, which corrected for differences 
in binding affinity, also revealed that the ability of PKG to attenuate 5-HT-induced 
contractions was virtually eliminated by chronic hypoxia in both fetal and adult arteries; 
4) the catalytic activity of total PKG was similar in fetal and adult arteries and was not 
affected by chronic hypoxia; and 5) the ability of PKG activation to reduce 5-HT-induced 
contractions was attenuated by pretreatment with the BK channel blocker iberiotoxin in 
normoxic but not hypoxic arteries from both fetus and adult. Given that these 
observations were made in endothelium-denuded arteries treated with L-NAME to inhibit 
NO synthase activity and with prazosin to inhibit activation of adrenergic receptors, this 
study focused on the ability of smooth muscle PKG to influence serotonergic contraction. 
Specifically, these observations support the hypothesis that chronic hypoxia acts directly 
on vascular smooth muscle to attenuate cGMP-induced vasorelaxation through reduced 
ability of PKG to activate BK channels.  Equally important, the results demonstrate that 
these effects of hypoxia on PKG-mediated inhibition of serotonergic contractions are 
markedly different in fetal and adult arteries.   
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Effects of Hypoxia and 8-pCPT-cGMP on 5-HT Efficacy and pKa 
Chronic hypoxia is well established as a major modulator of vascular structure, 
contractility, and vasorelaxant efficacy in many artery types (3, 25, 42). A key finding 
among previous studies is that chronic hypoxia can attenuate endothelial NO release 
through reductions in endothelial NO synthase-specific activity (35). In parallel, chronic 
hypoxia can also reduce relaxation responses to NO in part through reduced soluble 
guanylate cyclase activity, and in part through attenuation of the ability of 8-pCPT-
cGMP, a PKG activator, to promote vasorelaxation (46). These results support the 
hypothesis that chronic hypoxia depresses cGMP-dependent protein kinase activity. 
Consistent with these results, chronic hypoxia markedly attenuated the ability of 8-pCPT-
cGMP to inhibit contractile responses to 5-HT (Fig. 1). As previously reported, this effect 
of hypoxia was greater in adult than in fetal arteries (46).  For a majority of G protein-
coupled receptors, including those that mediate contractile responses to 5-HT, agonist 
binding affinity is subject to regulation through phosphorylation by multiple serine-
threonine kinases including PKC, PKA, and specific GPCR receptor kinases (1, 5). This 
evidence suggests that PKG could attenuate 5-HT-induced contraction through 
desensitization of the 5-HT-2a receptors that mediate contractile responses to 5-HT in 
ovine common carotids (42). To explore this hypothesis and its corollary that hypoxia 
attenuates this effect of PKG, our experimental approach examined the effects of the 
PKG activator 8-pCPT-cGMP on 5-HT binding affinity (pKa) and potency (pD2) in 
normoxic and hypoxic arteries (Fig. 2). Treatment with 8-pCPT-cGMP significantly 
depressed pKa at multiple concentrations in normoxic fetal and adult arteries, but at only 
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30 μM in hypoxic adult arteries, and was without effect in hypoxic fetal arteries. 
Conversely, in normoxic arteries 8-pCPT-cGMP significantly attenuated pD2 only at 30 
μM in fetal carotids, but in hypoxic arteries it significantly attenuated pD2 at multiple 
concentrations in both fetal and adult arteries. Together, these results demonstrate that 8-
pCPT-cGMP significantly modulates interaction between 
5-HT and its receptor through mechanisms that are sensitive to hypoxia. Given 
that pKa is determined primarily by interactions between a ligand and its receptor, but 
pD2 also includes influences of receptor density, the results are consistent with previous 
reports that hypoxia alters 5-HT receptor density (3).  The small sizes of these effects, 
however, suggest that influences on binding affinity and potency alone cannot explain the 
ability of hypoxia to ablate PKG-mediated attenuation of serotonergic contractions (Fig. 
1).  To correct for any effects of 8-pCPT-cGMP and hypoxia on 5-HT binding affinity 
and potency, the concentration-response relations shown in Fig. 1 were converted into 
occupancy-response relations using the Furchgott transformation (13).  This conversion 
eliminated the influence of changes in binding affinity and revealed changes in coupling 
between activated receptors and the contractile apparatus. As shown in Fig. 3, 8-pCPT-
cGMP still significantly attenuated 5-HT-induced contractility in normoxic, but not 
hypoxic, arteries. These results demonstrate that 8-pCPT-cGMP significantly depressed 
coupling between the 5-HT-2a receptor and the contractile apparatus in both fetal and 
adult arteries through mechanisms that were highly sensitive to the effects of chronic 
hypoxia. 
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Effects of Hypoxia on PKG Abundance and Specific Activity 
Downstream from receptor activation, a key determinant of the ability of 8-pCPT-
cGMP to alter 5-HT-induced contraction is the abundance of PKG. In turn, it is possible 
that hypoxic reductions in PKG abundance could explain hypoxic ablation of the ability 
of 8-pCPT-cGMP to reduce 5-HT-induced contractions.  To test this hypothesis, the 
experimental approach included abundance measurements of total PKG, which included 
contributions from both the Iα and Iβ isoforms (11).  These measurements indicated that 
neither postnatal age nor hypoxia had any significant effect on the abundance of total 
PKG (Fig. 4). These findings strongly demonstrated that hypoxic reductions in PKG 
abundance could not explain hypoxic ablation of the ability of 8-pCPT-cGMP to reduce 
5-HTinduced contractions in adult arteries; another mechanism must be involved. 
Another key determinant of the ability of 8-pCPTcGMP to alter 5-HT-induced 
contraction is the kinase activity of the PKG enzyme. Correspondingly, inhibition of 
PKG kinase activity could potentially explain hypoxic ablation of the ability of 8-pCPT-
cGMP to reduce 5-HT-induced contractions.  To test this hypothesis, our experimental 
approach included measurements of PKG-dependent kinase activity in artery 
homogenates. Consistent with the observed age-related differences in PKG abundance 
(Fig. 4), total tissue activity was greater in fetal than adult arteries. However, hypoxia had 
no significant effect on total PKG activity in either fetal or adult artery homogenates (Fig. 
5). Normalization of total tissue activities relative to PKG abundance further revealed 
that specific kinase activity for PKG varied with neither postnatal age nor hypoxia (Fig. 
5, inset). Together, these findings demonstrated that changes in neither PKG abundance 
nor specific kinase activity could explain hypoxic inhibition of 8-pCPTcGMP- induced 
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reductions in 5-HT-induced contractions. Equally important, these results suggest that 
effects of hypoxia on protein targets of PKG may explain hypoxic inhibition of PKG- 
induced attenuation of 5-HT-induced contractions. 
 
Interactive Effects of Hypoxia, 8-pCPT-cGMP, and Iberiotoxin on 5-HT 
Efficacy 
Among the many protein targets of PKG, one of the most prominent in regards to 
smooth muscle contractility is the BK channel (11, 29). Phosphorylation of S1072 by 
PKG directly promotes activation of the BK channel (12) and thereby hyperpolarizes the 
plasmalemma and promotes vasorelaxation (24, 47). These characteristics raise the 
possibility that PKG may attenuate 5-HT-induced contractions by activating the BK 
channel. In addition, it is possible that hypoxia in some way interferes with the ability of 
PKG to promote activation of the BK channel and thereby ablates the effects of PKG 
activation of 5-HT-induced contractility. To test this hypothesis, the experimental 
approach evaluated the effects of BK channel blockade on the ability of 8-pCPTcGMP to 
inhibit 5-HT-induced contractions. Blockade of BK channel currents relied on the effects 
of iberiotoxin, a well-defined and highly selective blocker of the BK channel (14).  
Previous studies from our laboratory have shown that 5-HT increases BK channel activity 
in sheep arteries, and that iberiotoxin at 100 nM can block this contribution (41).  To 
quantify contributions of BK channel activation to PKG-mediated inhibition of 5-HT 
efficacy, we repeated the 5-HT concentration-response experiments as shown in Fig. 1, in 
the presence of iberiotoxin. With this approach, the total effect of PKG was defined by 
the difference in 5-HT efficacy measured in the presence and absence of 30 M 8-pCPT-
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cGMP (Fig. 6).  Similarly, the BK-independent effect of PKG was defined by the 
difference in 5-HT efficacy measured in the presence of iberiotoxin either with or without 
30 μM 8-pCPT-cGMP. In turn, the BK-dependent component of PKG-mediated 
inhibition of 5-HT efficacy was the simple paired difference between the total component 
and the BK-dependent component of PKG-mediated inhibition. To simplify comparisons 
among these components, their average values were plotted in Fig. 7.  As shown in Figs. 
1, 6, and 7, hypoxia reduced total PKG-mediated inhibition of 5-HT efficacy in both fetal 
and adult arteries. The BK-independent component of PKG-mediated inhibition (Fig. 7, 
light gray) was significantly greater than the BK-dependent component in both fetal and 
adult arteries (Fig. 7, dark gray). More importantly, BK-independent component was not 
significantly different in normoxic and hypoxic arteries of either age group. This finding 
suggests that BK-independent mechanisms of PKG-mediated vasorelaxation, such as 
inhibition of calcium sequestration and release (8, 19), calcium influx (16), calcium 
extrusion (23), and myofilament calcium desensitization (30) are resistant to chronic 
hypoxia. In contrast, the BK-dependent component of PKG-mediated vasorelaxation was 
greater in fetal than adult arteries and was virtually ablated by chronic hypoxia in both 
age groups. These results extend previous findings in cultured pulmonary artery smooth 
muscle (36) and strongly suggest that hypoxic attenuation of PKG-mediated inhibition of 
5-HT efficacy is attributable to suppression of the BK-dependent component of PKG-
mediated vasorelaxation. 
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Overview 
The mechanisms whereby hypoxia suppresses PKG-mediated activation of BK 
channels remain uncertain.  These effects could be explained by hypoxic inhibition of BK 
channel expression, but support for this mechanism is not evident in the literature. 
Hypoxia has been shown to upregulate expression of the β regulatory subunit of the BK 
channel (49), but how this effect might help mediate hypoxic suppression of PKG-
mediated activation of BK channels remains to be demonstrated.  Similarly, the effects of 
chronic hypoxia on expression of the BK α-subunit also remain unreported. An alternate 
mechanism could involve a generalized hypoxic inhibition of BK activation (32), perhaps 
through depression of calcium sensitivity of the channel (10, 22). Hypoxic upregulation 
of generalized phosphatase activity could explain such an effect, but support for this 
mechanism is lacking. Another interesting possibility is that hypoxia alters the 
organization and distribution of PKG within the smooth muscle cell and thereby limits 
access of the kinase to its primary targets. Certainly, the mechanisms that mediate 
hypoxic inhibition of PKG-mediated activation of BK channels are worthy of future 
investigation (Fig. 8). Another worthy topic is how PKG inhibits agonist-binding affinity, 
and how this effect can be modulated by hypoxia; none of these mechanisms are known. 
What the present study does show is that hypoxia has little effect on PKG abundance or 
catalytic activity. Instead, hypoxia influences vascular smooth muscle to modulate the 
targets of PKG, including most prominently the BK channel. This finding raises new 
questions regarding possible effects of hypoxia on other PKG targets, what duration and 
severity of hypoxia are necessary to elicit these effects, and what other 
pathophysiological perturbations might produce similar effects.  The model used in the 
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present study was designed to assess the effects of maternal hypoxia on fetal 
oxygenation. Even though basal oxygen tensions under both normoxic and hypoxic 
conditions were markedly different in fetuses compared with non-pregnant adults, it is 
striking that the ability of hypoxic acclimatization to ablate PKG-mediated vasodilation 
of serotonergic contractions was similar in both adult and fetal sheep. This finding 
strongly suggests that a common mechanism of response to chronic hypoxia was 
operating in both adults and fetuses despite major differences in their ambient oxygen 
tensions. Although it is not certain that chronic hypoxia can ablate PKG-mediated 
inhibition of contractions induced by agonists other than 5-HT, it is conceivable that 
other calcium-dependent (27) and calcium-independent (21) signal transduction pathways 
might have a similar effect on BK channel function. Many contractile agonists utilize 
common intracellular IP3-dependent and calcium-dependent signal transduction 
pathways with potential to activate BK channels (44); it seems probable that other 
contractile agonists might reveal similar effects of chronic hypoxia (32). Conversely, 
preliminary results from our laboratory suggest that the effects of chronic hypoxia on the 
ability of PKG to attenuate tone may be specific for the agonist used to initiate 
contraction, particularly in fetal arteries. To fully evaluate how chronic hypoxia 
differentially influences the PKG-sensitive and agonist-specific components of 
contraction will require many additional studies.  Whether the observed loss of PKG 
function represents a pathophysiological consequence or a biologically advantageous 
adaptation remains an open question. What does seem clear is that chronic hypoxia 
depresses multiple components of the NO-cGMP-PKG vasorelaxation pathway including 
endothelium-dependent vasodilation (45), inhibition of endothelial NO release (35), and 
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inhibition of smooth muscle soluble guanylate cyclase activity (46). Because the patterns 
of PKG-dependent effects were similar in endothelium-intact and endothelium-denuded 
arteries, the present results further demonstrate that chronic hypoxia also depresses the 
ability of smooth muscle PKG to promote vasodilatation. The consequences of this 
pattern of effects remain uncertain but seem likely to enhance vasoconstrictor responses, 
which could help overcome typical hypoxic depression of contractility (32) but might 
also reduce the efficiency of flow-metabolism coupling and blood flow autoregulation. 
Such changes could increase vulnerability to, and could compromise recovery from, 
ischemic insults.  For example, this pattern of increased vulnerability could be 
particularly important for the neurovascular unit, where the fine balance between 
metabolism and perfusion determines cell fate following a major insult. Alternatively, 
increased contractility may help maintain peripheral vascular resistance and arterial 
pressure at altitude. Overall, these effects of chronic hypoxia on the NO-cGMP-PKG 
vasorelaxation pathway seem likely to be compensatory given that pregnant sheep and 
their fetuses thrive at high altitude. 
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Fig. 8. Schematic representation of the interactive effects of PKG and chronic hypoxia on 
5-HT induced contractions. Serotonin binds the 5-HT2A receptor to mobilize intracellular 
calcium and promote depolarization, which facilitates calcium influx and promotes 
contraction. Left side indicates large conductance calcium-sensitive potassium channel 
(BK)-independent effects of PKG, which include inhibition of agonist binding affinity. 
Right side indicates BK-dependent effects of PKG, which include direct or indirect 
activation of BK channels, with subsequent membrane hyperpolarization, attenuation of 
calcium influx, and reduced contraction. Chronic hypoxia inhibits both the effects of PKG 
on agonist binding affinity and the ability of PKG to activate BK channels. Hypoxia may 
also have other PKG-independent effects including stimulation of myofilament calcium 
sensitivity and inhibition of BK activation. 
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Perspectives and Significance 
From a clinical perspective, these results predict that vascular reactivity to both 
endogenous and exogenous NO should be significantly depressed in both neonates and 
adults adapted to chronic hypoxia due to attenuation of the ability of PKG to activate BK 
channels. The results also suggest, however, that a BK-independent component of PKG-
mediated vasorelaxation persists following hypoxic acclimatization, in which case 
increased activation of soluble guanylate cyclase or inhibition of phosphodiesterase might 
yield increased inhibition of vasoconstriction through BK-independent pathways (Figs. 7 
and 8).  Alternatively, hypoxia might also alter BK function, perhaps through PKC-
mediated phosphorylation of the BK channel, which can block the effects of subsequent 
phosphorylation by PKG (51, 52). Therapeutically, such an effect of PKC might be 
reversed by PKC inhibitors. Another alternate approach might be to drive the BK 
channels more directly through caffeine-induced activation of ryanodine receptors with 
subsequent release of subsarcolemmal calcium and BK channel activation (44). 
Identification of which of these approaches might be most efficacious in clinical settings 
awaits future experimentation. 
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CHAPTER THREE 
CHRONIC HYPOXIA ATTENUATES THE ABILITY OF PROTEIN KINASE G 
TO INFLUENCE BK POTASSIUM CHANNEL ACTIVITY IN CEREBRAL 
ARTERIES 
 
Abstract 
 Long-term hypoxia (LTH) attenuates nitric oxide (NO) induced vasorelaxation in 
ovine middle cerebral arteries. Because cGMP-dependent protein kinase (PKG) is an 
important mediator of NO signaling in vascular smooth muscle, we tested the hypothesis 
that LTH diminishes the ability of PKG to phosphorylate its target proteins and cause 
vasorelaxation.  Prominent among proteins that regulate vascular tone is the large 
conductance calcium-sensitive potassium (BK) channel, which is a substrate for PKG and 
is responsive to phosphorylation on multiple serine/threonine residues.  Given the 
influence of these proteins, we also examined whether LTH attenuates PKG and BK 
channel protein abundance and PKG kinase activity.  Middle cerebral arteries were 
harvested from normoxic and hypoxic (altitude of 3,820 m for 110 days) fetal and adult 
sheep.  These arteries were denuded and equilibrated with 95% O2-5% CO2 in the 
presence of nitro-L-arginine methyl ester (L-NAME) to inhibit potential confounding 
influences of events upstream from PKG.  Expression and activity of PKG-I were not 
significantly affected by chronic hypoxia in either fetal or adult arteries.  Pretreatment 
with the BK inhibitor iberiotoxin attenuated vasorelaxation induced by 8-pCPT-cGMP in 
normoxic but not LTH arteries. The spatial proximities of PKG with BK channel alpha- 
and beta-proteins were examined by use of confocal microscopy, which revealed a strong 
dissociation of PKG with these proteins after LTH.  These results support the hypothesis 
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that hypoxia reduces the ability of PKG to attenuate vasoconstriction in part through 
suppression of the ability of PKG to associate with and thereby activate BK channels in 
arterial smooth muscle.  
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Introduction 
LONG-TERM HYPOXIA (LTH) triggers adaptive responses in the developing 
fetus that can enhance long term risk for many pathologies (35). In particular, maternal 
and perinatal hypoxia induce changes in vascular structure and reactivity that manifest as 
reduced vascular compliance and capacity for vasorelaxation (32). Correspondingly, 
Nitric oxide (NO) and the NO pathway, which potently influence vascular tone and 
vasorelaxation, appear quite vulnerable to modulation by LTH (20). Hypoxia can 
compromise multiple components of this pathway including vascular endothelial function 
and eNOS activity, vascular soluble guanylate cyclase (sGC) abundance and activity, and 
cGMP-dependent protein kinase (PKG) activity (33). Given that PKG is a prominent 
endpoint effector of the NO pathway, this investigation focused on the influence of LTH 
and the ability of activated PKG to modify its target proteins and regulate vascular tone. 
 
Acute and Chronic Influence of PKG on Cerebral Vascular Smooth Muscle 
Given that vascular tone is largely a product of cytosolic calcium concentration 
([Ca2+]i) and myofilament calcium sensitivity, acute regulation of tone by PKG involves 
both terms of this equation (28). PKG influences [Ca2+]i by inhibiting release from the 
sarcoplasmic reticulum (SR); by stimulating extrusion via the plasma membrane Ca2+ 
ATPase transport protein (PMCA) and the Na+/ Ca2+ exchanger (15); and by stimulating 
sequestration via the sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) and the SR 
(9). Also, PKG-mediated phosphorylation of the large-conductance BK potassium 
channel alpha protein (BKα) increases its Ca2+ sensitivity (21), (46) and thereby 
indirectly inhibits Ca2+ entry by promoting hyperpolarization and attenuating voltage-
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gated Ca2+ channel activity. PKG also acutely influences myofilament Ca2+ sensitivity 
at numerous regulatory points, including activation of myosin light-chain phosphatase 
(MLCP) (29), phosphorylation of vasodilator-stimulated phosphoprotein (VASP) (23), 
the 20 kDa heat-shock protein-20 (HSP20) (6), and more. The BK channel is of particular 
interest as it is a dominant mediator of acute PKG-induced vasorelaxation (4), and is also 
vulnerable to the stress of LTH (38). Long-term influences of PKG involve its ability to 
promote and maintain the contractile vascular smooth muscle (VSM) phenotype, which is 
likewise vulnerable to LTH in this capacity. PKG or PKA action at ser133 on the cAMP 
response element-binding protein (CREB) promotes expression of VSM contractile 
proteins (7, 34). PKG also directly and indirectly regulates phenotype by influencing 
contractile gene expression via serum response factor (SRF) and myocardin (40). It has 
been shown that high PKG activity correlates with increased myocardin expression (45), 
and that myocardin promotes SRF binding to CArG promoter sequences. Also, PKG 
phosphorylation of ser104 on cysteine-rich protein-4 (CRP4) promotes cooperativity of 
GATA6 and SRF which likewise leads to increased SRF binding to CArG (43). In turn, 
SRF binding to CArG domains activates a repertoire of VSMC genes that characterize 
the contractile phenotype (43). More empirically, it has been shown that activation of 
PKG correlates with expression of VSM contractile proteins (24), and that hypoxia-
induced attenuation of PKG leads to repression of VSMC-specific genes (44), while 
overexpression of PKG reverses this. This implies a critical role for PKG in establishing 
and maintaining the contractile VSM phenotype. 
It is apparent that PKG plays a prominent role in acute and long-term establishment 
and maintenance of the contractile VSM phenotype via multiple pathways that are 
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vulnerable to the influence of LTH. Altered structure-function relations under hypoxic 
stress represent an adaptive homeostasis that favors near-term survival. And yet, 
mechanisms underlying the disruptive effects of LTH on the role of PKG in cerebral 
VSM remain largely unexplored. The observed loss of contractile function may represent 
a lower density of contractile proteins and therefore lower contractant efficacy; or a shift 
within the subpopulation of contractile VSMs to a synthetic phenotype; or it could 
represent, not exclusively, a reorganization or inactivation of the existing contractile 
apparatus. The main hypothesis is that hypoxia alters the ability of PKG to influence its 
target proteins, and the BK channel in particular, due in part to a structural re-
organization of effector proteins. A corollary to this is that maturation from fetus to adult 
influences the response to hypoxic stress. To test these ideas, it is of interest to quantify 
the relative influence of the BK channel in cerebral VSM under normoxic and hypoxic 
conditions. To accomplish this we used the selective BK channel inhibitor iberiotoxin to 
distinguish BK- vs. non-BK channel effects (8, 17, 36). In order to study vasorelaxation, 
we used 5-hydroxytryptamine (5-HT, aka serotonin) as a contractant, against which the 
effects of relaxation could be contrasted. Use of 5-HT required that we validate the effect 
of PKG and LTH independently on the 5-HT receptor (5-HTR) pathway; to this end we 
examined the influence of PKG and hypoxia on 5-HTR affinity and receptor occupancy. 
In this study we used middle cerebral arteries from fetal and adult sheep to examine two 
main endpoints:  a functional endpoint, the 5-HT concentration-response; and a structure-
relational endpoint, which was the organization among vasorelaxant proteins (PKG, BKα, 
BKβ1) as measured with confocal microscopy. 
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Materials and Methods 
All procedures in this study were approved by the Animal Research Committee of 
Loma Linda University and adhered strictly to the policies and practices set forth by the 
National Institutes of Health Guide governing the care and use of laboratory animals. A 
total of 50 sheep were used in this study of which 24 were term fetal lambs, including 13 
that were from high altitude, and 11 that were from low altitude; and 26 adult sheep of 
which 13 were from high altitude and 13 from low altitude. From these animals we 
harvested a total of 272 middle cerebral artery segments, including 132 fetal segments 
and 140 adult segments. A total of 104 segments were used for functional studies to 
measure contractile force, and 168 were used for organ culture and confocal imaging. 
Throughout the text, “n” represents the number of animals, and not the number of 
segments used in each experiment. Statistical significance implies P ≤ 0.05. All values 
are given as means ± SE. 
 
Tissue Harvest and Preparation 
All middle cerebral arteries used in this study were harvested from normoxic and 
chronically hypoxic term fetal (139–142 days gestation, where full term is 145) and 
young (18–24 mo. old) nulliparous adult sheep. Normoxic animals were obtained 
(Nebeker Ranch, Lancaster, CA; 720 m altitude) and brought to the LLU animal care 
facility (353 m altitude), where arterial oxygen tensions (PaO2) averaged 23 ± 1 Torr and 
102 ± 2 Torr in fetal and adult sheep respectively. Chronically hypoxic sheep were 
maintained for ~110 days at high altitude (altitude 3,820 m, Barcroft Laboratory, White 
Mountain Research Station, Bishop, CA). For pregnant ewes, the period at altitude 
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corresponded to the final 110 days of gestation. At high altitude, PaO2 values averaged 
19 ± 1 and 64 ± 2 Torr for fetal and adult sheep respectively. Sheep brought to our animal 
care facility from high altitude were maintained at low PaO2 by placement of a tracheal 
catheter that was ventilated with an N2-enhanced mixture of breathing gas to maintain an 
arterial PaO2 of ~60 Torr. For hypoxic study animals, arterial blood was obtained and 
monitored intermittently several times a day, and the breathing gas ratios were adjusted 
as necessary. Pregnant ewes were anesthetized with 30 mg/kg pentobarbital, intubated, 
and then placed on 1.5–2.0% halothane. The anesthetized fetus was then exteriorized 
through a midline vertical laparotomy and euthanized by rapid removal of the heart and 
exsanguination. Non-pregnant adult animals were euthanized by intravenous 
administration of pentobarbital sodium (100 mg/kg) and phenytoin sodium (10 mg/kg). 
Harvested middle cerebral arteries were placed in sodium Krebs buffer solution 
containing (in mM) 122 NaCl, 25.6 NaHCO3, 5.17 KCl, 2.49 MgSO4, 1.60 CaCl2, 2.56 
dextrose, 0.027 EGTA, and 0.114 ascorbic acid, bubbled with 95% O2-5% CO2. Arteries 
were subsequently debrided of loose extravascular and connective tissue, and the 
endothelium was substantially disrupted (herein referred to as “denuded”) by passage of 
an abrasive tungsten wire through the lumen followed by irrigation with Krebs buffer. 
Given that residual endothelial activity could potentially confound the results, NG-nitro-
L-arginine (L-NNA) and nitro-L-arginine methyl ester (L-NAME) and was added to the 
Krebs buffer to inhibit endothelial NO release and minimize soluble guanylate cyclase 
(sGC) activity. Functional studies on these prepared arteries commenced without delay. 
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Measurement of Agonist Binding Affinity and Receptor Occupancy 
The 5-HT-receptor dissociation constants were determined using the Furchgott 
method of partial irreversible blockade (14) with the alkylating agent phenoxybenzamine 
(50–150 nM), as previously described (19, 39). Using this method, pairs of artery 
segments were pretreated with the PKG activator 8-pCPT-cGMP across a range of 
concentrations from 0 to 30 µM to determine the influence of PKG. The final 
concentration of phenoxybenzamine was chosen to achieve a 50% decrease in 5-HT 
efficacy with a 30-minute incubation. Pairs of adjacent phenoxybenzamine-treated and -
untreated artery segments were then assayed to obtain concentration-response curves 
across a double reciprocal plot of 1/[A] versus 1/[A'] range of 10-10 to 10-4 M 5-HT. 
From these, a dissociation constant for the 5-HT receptor complex, Ka, was taken as the 
slope – (1/intercept). Using this, a fractional receptor occupancy [RA]/[RT] was 
calculated using the method described by Parker (31), where [RA]/[RT] = [A]/([A] + 
Ka). Here [RA] represents the concentration of the receptor-agonist complex, and [RT] is 
the total receptor concentration.  
 
PKG Abundance and Activity 
Middle cerebral artery segments were homogenized using glass-on-glass mortars 
and pestles in 50 mM HEPES buffer (pH 7.4), containing 2 mM magnesium acetate, 2 
mM DTT, 1 mM EDTA, 520 μM 4-(2-Aminoethyl)-benzenesulfonyl fluoride 
hydrochloride (AEBSF), 7.5 μM pepstatin-A, 7 μM E 64, 20 μM bestatin, 100 μM 
leupeptin, and 0.4 μM aprotinin. Supernatants were collected after centrifugation at 
100,000 xG for 1 h at 4 °C and analyzed for protein content using the Bradford assay, as 
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previously described (3). Aliquots were then divided for separate analysis of PKG 
abundance by Western blot and PKG kinase activity. Relative abundances of PKG-α and 
-β isoforms were determined by use of SDS-PAGE separation and visualized using 
methods previously described in detail by our laboratory (38). Relative abundances of 
total PKG were normalized to standards prepared from arteries harvested from adult 
normoxic non-pregnant ewes. PKG kinase activity was determined using aliquots of 
supernatants from the above homogenates using methods described previously in detail 
by our laboratory (38). Briefly, samples were incubated for 30 minutes, added to a 
homogenizing reaction buffer in 96-well plates containing [γ-32P]ATP (NEN), a PKG 
substrate BPDEtide (200 μM) (BMLP112-0001, Enzo Life Sciences), and 8-pCPT-cGMP 
(10 µM). Timed reactions were terminated by addition of phosphoric acid, and then 
phosphorylated BPDEtide and unreacted [γ-32P]ATP were separated through 
phosphocellulose filter paper. Washed filters were added to vials with a scintillation 
cocktail and assayed using a liquid scintillation counter. Counts were converted into 
picomoles 32P by use of a calibration curve that was produced concurrently with the 
samples and normalized to sample protein content to obtain PKG kinase activity, 
expressed as pmol 32P transferred per minute per milligram of protein. Each assay 
included controls using: 1) no added 8-pCPT-cGMP; 2) no added BPDEtide substrate; 
and 3) neither 8-pCPT-cGMP nor BPDEtide to correct for total nonspecific background. 
 
BK Channel Protein Abundance 
Middle cerebral arteries (MCAs) from fetal and newborn sheep were harvested, 
debrided, rapid-frozen in liquid nitrogen and stored at -80 °C. Tissues were subsequently 
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homogenized using glass-on-glass in RIPA extraction buffer containing 10 mM DTT and 
a protease inhibitor cocktail (Sigma-Aldrich, Saint Louis, MO #M1745). Samples were 
centrifuged at 5000 xG for 20 minutes, then supernatants were collected and analyzed 
using SDS-PAGE along with reference control samples from pregnant adult sheep 
MCAs. Separated proteins were transferred to nitrocellulose membranes at 200 mA for 
90 minutes in Towbin buffer (25 mM Tris, 192 mM Glycine, and 20% Methanol). 
Membranes were blocked using 5% milk in Tris-buffered saline at pH 7.45 (M-TBS) for 
1 hour at room temperature with continuous shaking. Primary antibodies were incubated 
for 12 hours at 4°C using the following dilutions for BK-α 300:1 (Alomone, Jerusalem, 
Israel. #APC-021) and BK-β1 300:1 (Alomone #APC-036). For visualization, 
membranes were incubated for 90 minutes with a secondary antibody conjugated to 
DyLight 800 (Pierce Chemical, Rockford, IL #46422). Subsequently, membranes were 
stripped and re-probed using antibodies against β-Actin (Sigma-Aldrich #A2228 
monoclonal anti-β-Actin produced in mouse, clone AC-74) as a loading control. Anti-β-
Actin was diluted using a factor of 1:5000, and incubated for 90 minutes in M-TBS 
buffer with 0.1% Tween-20. Membranes were imaged on LI-COR Bioscience’s Odyssey 
system and individual protein bands were quantified using LI-COR Image Studio® 
software. Protein abundance was normalized using β-Actin as a loading control, and 
expressed as a relative abundance compared with an arbitrary reference standard (pooled 
whole-cell lysate obtained from pregnant adult sheep middle cerebral arteries). 
 
5-HT Concentration Response 
Denuded ovine MCAs were cut into segments about 3 mm in length, mounted on 
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tungsten wire loops, and suspended from a force transducer in a sodium Krebs buffer 
solution (pH 7.4) at 38 °C (the ovine core temperature) and bubbled with 95% O2 and 
5% CO2. Nitro-L-arginine methyl ester (L-NAME) (10 µM) and NG-nitro-L-arginine (L-
NNA) (10 µM) were added to the Krebs buffer solution to inhibit endogenous nitric 
oxide (NO) production and sGC activation. To selectively inhibit activation of α1-
adrenergic receptors by 5-HT, and synaptic uptake of 5-HT, 1.0 µM prazosin and 0.2 μM 
cocaine were added, respectively. In preliminary experiments, both endothelium-intact 
and endothelium-denuded segments were studied. Removal of endothelium did not affect 
contractile efficacy, but reduced its variability; therefore, further experiments were 
performed using endothelium-denuded segments. The denuded segments were 
equilibrated for 30 minutes and then stretched to a baseline tension of 0.75 g (fetal) or 1.5 
g (adult), which corresponded with an optimal stretch ratio of ~1.8 times the unstressed 
diameter. Contractile force was measured directly using an isometric force transducer 
(Kent Scientific, Torrington, CT) and recorded directly by computer in real time using a 
LabView®-based instrument interface. Concentration-response curves were obtained by 
cumulative addition of half-log concentrations of 5-HT across a range of 10-10 to 10-4 
M. In these experiments 5-HT was the contractant of choice, in part because it was 
previously validated in our laboratory (37), and preliminary experiments using 
norepinephrine showed it to be significantly less potent, less efficacious and more 
variable than 5-HT in producing contractions in cerebral VSM; therefore, all further 
experiments were performed using 5-HT. EC50 values (molar concentration at which the 
contractile response was half the maximal induced contraction) were expressed as pD2  
values (-log EC50). All contractile responses were normalized to the maximum force 
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produced by exposure to a potassium-Krebs solution containing (in mM) 5.17 NaCl, 25.6 
NaHCO3, 122 KCl, 2.49 MgSO4, 1.60 CaCl2, 2.56 dextrose, and 0.027 EGTA. To 
measure the relative contribution of large conductance calcium-sensitive potassium (BK, 
KCa1.1) channels to 5-HT contractions, concentration-response experiments were carried 
out in the presence or absence of the selective BK channel blocker iberiotoxin at a 
concentration (100 nM) that previous work has shown to be optimal. Iberiotoxin was 
added to the baths, in both the presence and absence of 30 µM 8-(4-chlorophenylthio)-
guanosine-3’,5’-cyclic monophosphate (8-pCPT-cGMP) 20 min before starting the 
concentration-response measurements. 
 
Confocal Imaging Microscopy 
Fetal and adult hypoxic and normoxic middle cerebral arteries were harvested, 
debrided and sectioned into 3-mm segments. Segments were fixed in 4% 
paraformaldehyde (PFA) for 24 hours, then transferred to PBS until further processing. 
Fixed artery segments were then imbedded in paraffin and cut into 5 µm sections and 
mounted onto glass slides for immunohistochemistry processing and staining. BKα 
protein was labelled using a primary antibody (Alomone APC-021 rabbit polyclonal, or 
Santa Cruz cat# SC-33607, goat polyclonal) and then counterstained using a fluorescent 
tagged secondary antibody, donkey anti-rabbit (Thermo-Fisher Alexa Fluor® 633 cat# A-
21070), or donkey anti-goat (Thermo-Fisher cat# A-11055 Alexa Fluor® 488 nm). BKβ1 
protein was labelled using a primary antibody (Alomone APC-036) and counterstained 
using a fluorescent tagged secondary antibody, donkey anti-rabbit (Thermo-Fisher cat# 
A-21206 488 nm,). PKGα protein was labelled using a primary antibody specific for a 
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100 aa n-terminal epitope (Enzo Life sciences cat# ADI-KAP-PK005-F, rabbit 
polyclonal), and counterstained using a fluorescent tagged secondary antibody, donkey 
anti-rabbit (same as above). Stained tissues were illuminated at 488 nm with a krypton-
argon laser, and at 633 nm with a helium-neon laser. The emitted light was collected 
using a photomultiplier tube with a band-limited spectral grating in the range 500–600 
nm for Alexa Fluor 488 images (peak excitation/emission 496/519 nm) and 600-700 for 
Alexa Fluor 633 images (peak excitation/emission 632/647 nm). Images were acquired 
using an Olympus FV1000 confocal microscope and using Olympus FluoViewTM 
imaging software (Olympus Scientific Solutions, Waltham, Massachusetts). 
 
Determination of Protein Colocalization - Quadrant Analysis 
Images that were acquired using confocal microscopy were analyzed to determine 
protein colocalization using Colocalizer Pro® software (CoLocalization Research 
Software, Switzerland). These TIFF images contained separate plates for each 
fluorochrome, and thus each separate protein of interest, as well as a merged image which 
artificially appeared as yellow and represented a spatial colocalization of the two proteins 
within each separate voxel (146x146x545 nm @488 nm green; 185 x 185 x693 nm @ 
633 nm red). Although this colocalization did not prove a functional relationship, it did 
provide a solid quantitative basis for any potential cooperativity between any two given 
proteins. Individual red and green pixels from these images were separately quantified 
and plotted on a two-dimensional grid (Fig. 7a). Background noise intensities were 
removed using a 12% (31/255 instrument range) threshold on both axes, based on the 
pixel intensity distribution of control samples and apparent population boundaries. High 
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and low intensity thresholds were set at 50% (128/256 instrument range) for both red and 
green axes based on a median population distribution of a set of reference control 
samples. This 50% high-low threshold was maintained consistently throughout all 
subsequent analyses. The two-dimensional distribution and the 50% threshold boundaries 
thus define a four-quadrant grid (figure 7, inset). Given that voxel dimensions for the 
separate wavelengths are not identical, this presents a volume accessible to the longer 
wavelength (red) that is not accessible to the shorter wavelength (green). To eliminate 
this bias, we limited the analysis to only colocalized pixels above the 12% threshold. 
Pixels where one or both wavelength signal intensities were below the 12% threshold 
were not considered in the analysis. Thus the sum of all colocalized pixels above the 12% 
threshold represents a denominator for calculating the relative fraction of colocalized 
pixels in each representative quadrant for each study group (FN, FH, AN, AH). Quadrant 
1 (Q1) represented the fraction of pixels with simultaneous high-red and high-green 
intensities. Likewise, Quadrants Q2 and Q4 represented low-green/high-red, and high-
green/low-red respectively. Quadrant Q3 was low intensity on both axes. Using this 
approach, separate images were analyzed for each protein pair of interest (BKα with 
BKβ1, PKG with BKα, and PKG with BKβ1). 
 
Determination of Protein Proximity Index (PPI) 
 A protein proximity index (PPI) was calculated for each protein pair of interest 
using the method described earlier by Zinchuk et al (47) together with the “Protein 
Proximity Analyzer” software (“PPA”, kindly provided by the Department of 
Anesthesiology, David Geffen School of Medicine, UCLA). Each of the two methods 
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employed (quadrant analysis and PPI analysis) arrived with different algorithms for 
eliminating noise. Using PPI analysis, ratios of auto-correlation to cross-correlation 
parameters were taken as a measure of true protein-protein proximity within the limits of 
each voxel dimension (41). Noise was eliminated by an algorithm that recognized a 
“slow-decay” surface on a 3-dimensional mesh plot. Calculated PPI values for each 
protein pair were represented wherein each protein appeared in the denominator 
separately, in a manner reminiscent of classical Mander’s correlation coefficients, e.g. 
[P1+P2]/P1TOT, and [P1+P2]/P2TOT, where [P1+P2] represented colocalized protein 
signal within a given quadrant, and P1,2TOT represented the total protein signal for a 
given wavelength above the 12% threshold. In ideal conditions where statistical noise and 
pseudo-colocalization were perfectly eliminated, the PPI index would represent the actual 
ratio of colocalized protein. 
 
Data Analysis and Statistics 
Significant differences in contractile variables were determined using Behrens-
Fischer tests for two-group comparisons, and ANOVA followed by Duncan’s post hoc 
simultaneous comparisons of more than 2 groups. Analyses using SPSS® software (SPSS 
v22, IBM Corporation, Armonk, NY) confirmed homogeneity of variance and normal 
data distributions in all reported experiments. Determinations of pKa values were based 
on double reciprocal plots from which slopes were determined by linear regression as 
described by Furchgott (14). Contractile forces were normalized relative to the 
contraction produced by exposure to isotonic 120 mM potassium-Krebs in the same 
artery segment. The relative influence of PKG stimulation on the BK potassium channel 
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compared with all other downstream targets was estimated using an algebraic model 
introduced previously (38) where a = maximum response to 5-HT in control arteries 
(untreated), b = total maximum response to 5-HT in the presence of PKG stimulation by 
8-pCPT-cGMP, c = maximum response to 5-HT in presence of iberiotoxin, and d = 
maximum response to 5-HT in the presence of iberiotoxin and with pre-treatment using 
8-pCPT-cGMP. The total effect of PKG activation was defined as (a-b), and the effect of 
PKG activation independent of BK channel activity was defined as (c-d). The BK 
channel-dependent effect of PKG activation was calculated as (a-b) – (c-d). Maximum 
efficacy of 5-HT was calculated using SPSS® and GraphPad® (GraphPad Software, Inc. 
La Jolla, CA) with a non-linear regression model using the four-parameter Hill equation 
{e + ( (f - e) / (1 + 10^(([agonist] - g) × h)))}, where “e” represents the calculated Emax, 
and f, g, and h are Hill coefficients. 
 
Results 
Effects of Hypoxia, Age, and 8-pCPT-cGMP on 5-HT Concentration-
Response Relations 
Hypoxia had a strong effect on the maximal vasorelaxation in response to 
treatment with graded concentrations of 8-pCPT-cGMP up to the maximum of 30 µM in 
both fetal and adult arteries (Fig. 1, left panels). Hypoxia did not significantly affect the 
response to the maximal 5-HT concentration (Emax) in untreated fetal arteries (69.7 ± 3.8 
normoxic vs. 77.2 ± 2.9 hypoxic), (Fig. 1a, top panels), but had a modest effect in adult 
arteries (69.9 ± 16.8 normoxic vs. 96.7 ± 17.7 hypoxic) (Fig. 1a, lower panels). By 
contrast, maturation had a significant effect on Emax among hypoxic (77.2 ± 16.7 fetal 
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vs. 96.7 ± 17.7 adult), but not normoxic (69.7 ± 24.1 fetal vs. 69.8.7 ± 16.8 adult) arteries 
(Fig. 1a, upper vs. lower panels). Loss of 8-pCPT-cGMP-dependent vasorelaxation 
potential among both hypoxic fetal and adult arteries was the main finding of this 
experiment. Owing to the robust response to 30 µM 8-pCPT-cGMP, this concentration 
was used in subsequent experiments throughout. 
 
Effects of Hypoxia, Age, and 8-pCPT-cGMP on 5-HT Agonist Potency 
The potency (pD2, or -log EC50) of 5-HT was significantly and similarly 
attenuated by 8-pCPT-cGMP in both fetal and adult arteries (Fig. 1b).  Hypoxia increased 
the pD2  values for 5-HT in untreated adult but not fetal arteries.  Correspondingly, 8-
pCPT-cGMP did not significantly affect 5-HT pD2 values in hypoxic fetal arteries, but 
significantly decreased these values in hypoxic adult arteries (Fig. 1b).  The 5-HT pD2 
values were similar in untreated normoxic fetal and adult arteries, but were significant 
less in untreated hypoxic fetal than in hypoxic adult arteries (6.8 ± 0.3 fetal vs. 7.2 ± 0.13 
adult).  
 
Effects of Hypoxia, Age, and 8-pCPT-cGMP on 5-HT Receptor Binding 
Affinity 
Values for 5-HT binding affinity (pKa) as a function of 8-pCPT-cGMP 
concentration were significantly altered only in normoxic fetal arteries (6.32 ± 0.23 at 0.0 
µM 8-pCPT-cGMP vs 5.82 ± 0.49 at 30.0 µM 8-pCPT-cGMP) (Fig. 2a, first panel). Long 
term hypoxia attenuated this depressant influence of 8-pCPT-cGMP on 5-HT binding 
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affinity in fetal arteries. Adult arteries were unaffected by hypoxia with regard to any 
influence of 8-pCPT-cGMP on 5-HT binding affinity.  
 
Effects of Hypoxia, Age, and 8-pCPT-cGMP on 5-HT Receptor Occupancy-
Response Relations 
To correct for the observed differences in 5-HT receptor binding affinity, 
particularly with fetal arteries, the concentration-response relations for 5-HT were 
converted to occupancy-response relations by the method described by Parker (28), and 
using the experimentally determined pKa values (Fig. 2b).  Any differences attributable 
solely to the effects of hypoxia on receptor affinity were fully compensated by this 
correction for receptor occupancy. In the converted occupancy-response curves, the 
effects of 8-pCPT-cGMP on contractile responses persisted in normoxic arteries, but 
were still attenuated in hypoxic arteries, indicating that the observed changes in the 
influence of 8-pCPT-cGMP on vasorelaxation involved effects independent of changes in 
receptor binding affinity, and that hypoxia acted downstream from the 5-HT receptor 
binding event.  The 8-pCPT-cGMP-induced decrease in contractile responses to 5-HT as 
a function of receptor occupancy were significant in both fetal and adult normoxic 
arteries (38.0 ± 12.1 and 26.05 ± 9.7 respectively) (Fig. 2b left panels); whereas in 
hypoxic arteries, induced vasorelaxation is not significantly different compared with 
controls (-1.4 ± 10.2 and 8.9 ± 7.0 respectively) (Fig. 2b right panels) at maximum 
receptor occupancy. 
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Effects of Hypoxia, Age, and 8-pCPT-cGMP on PKG Abundance and Specific 
Activity 
PKG-I exists in two splice-variant isoforms, designated PKG-Iα and PKG-Iβ. 
Total PKG was determined by Western blot using an antibody that recognizes a common 
epitope. Relative abundances were further normalized to adult normoxic values 
(AN=100%) to emphasize similarities and differences in protein expression. Total PKG 
abundance showed only slight and non-significant variation among the four study groups 
(FN, FH, AN, AH), as did the PKG-Iα isoform (Fig. 3a). The PKG-Iβ isoform was 
significantly more abundant in the fetal compared with adult arteries, but was not 
significantly affected by LTH. Although the fetal PKG-Iβ isoform was of higher 
abundance compared with adult arteries, the influence of PKG-Iβ on total PKG 
abundance was minimal, implying that it was of lower over-all abundance compared with 
PKG-Iα and contributed less to the measure of total PKG expression. 
Whole artery PKG kinase activity was unaffected by maturation (fetal vs. adult), 
nor by LTH. The timed kinetic assay showed no significant differences in kinase activity, 
expressed as nmol 32Pi-labeled BPDE/unit PKG (Fig. 3c). The kinetic rates (specific 
activity) were likewise nearly identical among the four study groups (AN, FH, AN, AH), 
expressed as nmol 32Pi-labeled BPDE/minute/unit PKG. Fetal PKG specific activity 
showed a slight but not significantly higher trend compared with the adults; and the 
normoxic fetal and adult specific activity appeared slightly but not significantly higher 
than their hypoxic counterparts. Importantly, any measured differences in PKG 
abundances as previously measured (above) were not reflected in their functional kinase 
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activity. Neither PKG abundance nor activity were able to account for hypoxic 
attenuation of PKG-induced depression of contractile responses to 5-HT. 
 
Interactive Effects of 8-pCPT-cGMP And Iberiotoxin on 5-HT-Induced 
Contraction 
Treatment of arteries with 8-pCPT-cGMP significantly attenuated 5-HT efficacy in 
all study groups (Fig. 4a, Ctrl vs. 8-pCPT-cGMP). Pretreatment with iberiotoxin alone 
increased 5-HT efficacy in all arteries; but addition of 8-pCPT-cGMP to iberiotoxin 
treated arteries demonstrated a persistent but diminished vasorelaxation, indicating a 
significant component of non-BK channel mediated vasorelaxation (Fig. 5a, Iberiotoxin 
vs. Iberiotoxin + 8-pCPT-cGMP). The relative contributions of BK- vs. non-BK channel 
mediated vasorelaxation was quantified using our algebraic model. This showed that in 
hypoxic arteries the BK-independent component had a small but not significant 
attenuation. By contrast, the BK-dependent PKG-mediated vasorelaxation was nearly 
abolished in both fetal and adult arteries (Fig. 4b). 
 
Effects of Hypoxia and Age on BK Protein Isoform Abundance 
The abundance of BKα and BKβ1 was measured by Western blot. Across both 
age groups, ANOVA revealed a significant depression of abundance for BKα that was 
individually significant by Student’s-T in fetal (1.20 ± 0.10 FN vs. 0.67 ± 0.08 FH, p ≤ 
0.02) but not adult (2.46 ± 0.51 vs. 1.89 ± 0.51, ns) arteries (Figure 5b).  The effects of 
hypoxia on BKβ1 abundance were not significant in either age group. 
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Effects of Hypoxia and Age on Protein Colocalization 
Visual inspection of merged confocal images provided insight into the extent and 
magnitude of protein colocalization, where red or green represented individual proteins of 
interest, and yellow shades (artificially) represented a spatial convergence of separate red 
and green pixels (Fig. 6). Normoxic artery images among all four study groups, and for 
each of the three protein pairs contained noticeably more yellow-shaded pixels within the 
medial layer compared with their hypoxic counterparts.  Representative scattergrams for 
fetal normoxic and hypoxic middle cerebral arteries demonstrated a substantial loss of 
protein colocalization secondary to LTH (Fig. 7a). “Colocalization” in this context was 
defined as a concurrency of two separate proteins within the confines of each voxel 
interrogated. This defined a linear separation range of 0-583 nm, i.e. the extreme corners 
of each individual rectangular 146x146x545 nm voxel. Each of the six protein pairs 
examined showed qualitatively similar scattergrams (not shown). For the protein pair 
BKα with BKβ (Fig. 7a), the vertical axis (λ633, red) represented BKα, and the 
horizontal axis (λ488, green) represented BKβ1 across the full resolution (intensities of 0-
255) of the analysis software. Quadrant 1 (high BKα, high BKβ1) was nearly depleted of 
colocalized pixels in the fetal hypoxic panel. Quadrant 1 colocalization expressed as a 
fraction of the total revealed that LTH significantly affected all three protein pairs (BKα 
with BKβ1, PKG with BKα, and PKG with BKβ1) in both fetal and adult arteries (Fig. 
7b, histogram). Maturity (fetal vs. adult) displayed a modest but not significant effect on 
colocalization of BKα with BKβ1, and PKG with BKβ1 in normoxic cerebral arteries. 
Maturity had no significant effect on colocalization of any protein pairs among hypoxic 
arteries. 
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A calculated protein proximity index (PPI) using these same images corroborated 
the results from the above quadrant analysis. A histogram of PPI results (Fig. 8c) likewise 
showed that LTH significantly depressed colocalization of BKα with BKβ1 as a ratio of 
total BKβ1 protein [(BKα+BKβ1)/BKβ1] in both fetal and adult arteries (first panel). 
LTH also depressed the [(PKG+BKα)/PKG] and [(PKG+BKβ1)/PKG] PPI indices in 
both fetal and adult arteries (panels 3 & 4). LTH had less influence on the PPI index of 
BKα colocalized with BKβ1 expressed as a ratio to total BKα [(BKα+BKβ1)/BKα] 
(panel 5). However, maturity had a small but significant influence on the 
[(BKα+BKβ1)/BKβ1] PPI index as well as the [(PKG+BKα)/BKα] and 
[(PKG+BKβ1)/BKβ1] indices among LTH but not normoxic arteries (panels 2, 5, 6). 
 
Discussion 
This study on the effects of long term hypoxia in endothelium-denuded ovine 
cerebral arteries offered five main observations: 1) the PKG influence on 5-HT receptor 
affinity was diminished with LTH, but this represented only a minor contribution; 2) 
activation of PKG to induce vasorelaxation was significantly less effective in both fetal 
and adult LTH acclimatized cerebral arteries; 3) PKG abundance and specific activity 
were unaffected by LTH; 4) BK channel protein abundance was modestly downregulated 
with LTH, BKα more than BKβ1, and fetal more than adult; 5) structural organization of 
key vascular proteins was strongly affected by LTH and may have accounted partially for 
the observed functional loss of PKG-mediated vasorelaxation.  
The role of vascular endothelium and the NO pathway as a mediator of 
vasorelaxation has been well studied. This work has consistently shown that the role of 
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the endothelium as a master regulator of vascular tone is reliant on endogenous PKG, 
which serves as the main end effector of this pathway. Previous work in carotid arteries 
(38) has shown that a substantial component of the loss of PKG influence following 
hypoxic adaptation occurs independently of the endothelium and the NO pathway. Of 
greater clinical importance are the hypoxic adaptations within cerebral arteries, and 
cerebrovascular VSM in particular. To this end, we set about to directly examine the role 
of PKG, as well as those of its target proteins, to identify specific mechanisms responsive 
to hypoxic stress. As a first approach, completion of 5-HT concentration-response 
experiments yielded insight into the contractile effects of PKG activation under varying 
conditions of oxygen availability and developmental maturity. 
 
Concentration-Response of 8-pCPT on 5-HT Potency and Efficacy 
Graded hemilog concentrations of 8-pCPT-cGMP yielded corresponding 
responses to 5-HT in normoxic fetal and adult arteries (Figure 1a). In contrast, the effects 
of 8-pCPT-cGMP were strongly attenuated in hypoxic arteries. Interestingly, increasing 
concentrations of 8-pCPT-cGMP also significantly diminished 5-HT potency (pD2) in all 
but hypoxic fetal arteries (Figure 1b). These changes in pD2 in LTH acclimatized arteries 
suggested possible changes in binding affinity attributable to PKG. This raised a question 
about the role of the 5-HT receptor in hypoxic adaptation, its possible interaction with 
PKG, and whether this could be of sufficient magnitude to account for the observed loss 
of PKG effectiveness in LTH. To answer this, we more directly examined the influence 
of PKG on the 5-HT receptor. 
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Influence of PKG on Events Downstream from 5-HT Receptor Binding 
The 5-HT2 receptor is a member of the G-protein coupled receptor (GPCR) 
super-family (10). Phosphorylation of the 5-HT2 receptor by cyclic nucleotide-dependent 
kinases and G-protein receptor kinases (GRKs) can promote binding of beta-arrestins that 
influence receptor behavior including agonist binding affinity and intracellular coupling 
(18, 27). Furthermore, affinity is biologically regulated, which establishes a rationale for 
examining effects of PKG on pKa (26). These experiments demonstrated an influence of 
PKG on 5-HT2 receptor ligand binding affinity, albeit of low magnitude (Fig. 2a). 
However, the observed efficacy of 5-HT is a product of binding affinity (pKa), 
membrane receptor density and coupling efficiency. To correct for variations in observed 
5-HT2R affinity, we converted 5-HT concentration-response curves to receptor 
occupancy curves. If loss of PKG-induced vasorelaxation were attributable to alterations 
in receptor binding affinity, this correction would abolish the effects of 8-pCPT-cGMP 
on 5-HT-induced contraction. In contrast, the effects of PKG persisted (Fig. 2B), 
indicating that the effects of hypoxia on PKG-mediated inhibition of vasoconstriction 
were predominantly downstream from the 5-HT receptor binding event. This raised a 
more obvious question: could changes in PKG abundance or activity account for the 
observed loss of its influence in LTH acclimatized arteries? 
 
Effects of Hypoxia on PKG Abundance and Specific Activity 
Differentiated vascular smooth muscle expresses PKG predominantly as two 
splice variant isoforms, PKG-Iα and PKG-Iβ, which exclusively express the first (1α) or 
second (1β) coding exon of the PRKG gene (30). By Western blot, the abundance of 
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PKG-Iα was not significantly altered by LTH nor by maturity (Figures 3 a, b). The 
abundance of PKG-Iβ was significantly greater in fetal compared with adult arteries (Fig. 
3b), but was not significantly altered by hypoxia. Furthermore, age-related differences in 
PKG-Iβ abundance did not significantly influence total PKG expression, indicating that 
PKG-Iβ was proportionally far less abundant than PKG-Iα. Because only the PKG-Iα 
isoform typically is associated with regulation of cytosolic calcium and myofilament 
calcium sensitivity (2, 16), variations in PKG-Iβ abundance probably had little influence 
on the vasorelaxant effects of 8-pCPT-cGMP. In light of these results, we concluded that 
changes in overall PKG abundance could not account for the observed loss of PKG-
mediated inhibition of contraction in LTH adapted arteries.  Thus, we next examined 
PKG kinase activity under conditions of normoxia and hypoxia. Given that PKG has 
multiple phosphorylation sites that influence its catalytic activity (13), it was conceivable 
that LTH could influence PKG specific activity independent of its abundance. However, 
measurement of PKG total and specific activity revealed no significant effects of LTH in 
either fetal or adult arteries (Fig. 3c).  Given that neither PKG abundance nor activity 
were altered by LTH, the focus of this study next shifted to identification of one or more 
PKG substrates that might be altered by LTH. 
 
Effects of LTH on 8-pCPT-cGMP Mediated Attenuation of 5-HT-Induced 
Contraction 
Prominent among PKG substrates is the BK channel, which has a major role in 
mediating vasorelaxation (21). Pretreatment with iberiotoxin, a BK channel antagonist, 
can identify the influence of the BK channel apart from the collective non-BK channel 
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components of vasorelaxation (8, 17, 42).  We have previously used this principle to 
develop an algebraic model that can quantify the relative importance of the BK channel 
in PKG-mediated vasorelaxation (38). When we used this approach with LTH-
acclimatized middle cerebral arteries, two main observations emerged. First, PKG 
activation induced significant vasorelaxation in both normoxic and hypoxic arteries from 
both fetuses and adults, but the magnitude of this effect was strongly diminished in 
hypoxic arteries only (Figure 4a and b).  Second, iberiotoxin revealed that hypoxia 
independently downregulated both BK- and non-BK channel-mediated components of 
vasorelaxation, but had considerably more influence on the BK component. Given the 
demonstrated importance of the BK channel in mediating vasorelaxation, and its 
sensitivity to hypoxia, our experimental approach next determined if LTH-mediated 
decreases in BK channel protein abundances might help explain hypoxic inhibition of 
PKG-induced attenuation of 5-HT contractions. 
 
Effects of Hypoxia on BK Channel Protein Abundances 
Arteries acclimatized to LTH exhibited a consistent but modest attenuation of 
BKα abundance across both age groups (ANOVA P < 0.005) that was particularly strong 
in fetal arteries (p < 0.02), (Fig. 5b left panel). Conversely, BK-β1 abundance was not 
significantly altered by LTH (Fig. 5b right panel).  Whereas the decrease in BKα 
abundance could contribute to the observed loss of PKG regulatory influence, especially 
in fetal hypoxic arteries, the magnitude of this decrease was not proportional to the 
magnitude of the loss of vasorelaxation secondary to hypoxia (Fig. 4b).  This suggested 
that alterations in BK protein expression may influence vascular responses to PKG 
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activation following LTH acclimatization, but these decreases were probably not the 
dominant effect of LTH, particularly in adult arteries. Other possible effects of LTH on 
the vascular influences of PKG independent of PKG activity include changes in its 
trafficking, subcellular localization, as well as the proximity and affinity for possible 
substrates. For example, protein kinase C (PKC) has been shown to influence the ability 
of PKG to recognize, bind and then phosphorylate the BKα protein (46). How LTH 
modulates the vascular influences of PKG through changes in its trafficking and 
subcellular organization remain largely unstudied. To gain insight into the possible 
effects of LTH on cellular protein organization, we next examined the structural-spatial 
relations of PKG with BK channel proteins using confocal microscopy. 
 
Effects of LTH on the Cellular Organization and Confocal Colocalization of 
Vascular Proteins 
Homogenization of vascular tissue for the purpose of measuring kinase activity 
disrupts protein organization, scaffolding, and protein-protein relationships that may be 
essential for in vivo behavior. To explore the importance of physiological conditions that 
might reflect vascular adaptation to LTH, we measured the structural proximity of three 
highly interactive proteins that govern vascular tone: PKG, BKα, and BK-β1. These three 
proteins rely on direct contact and interaction to effect changes in vascular tone. PKG has 
a substrate recognition domain that mediates substrate binding, and is distinct from its 
catalytic domain (13). Loss or diminution of direct contact between PKG and its target 
substrates predict a loss of kinase activity and function. Similarly, direct association of 
BK-β1 with its BKα counterpart within the plasmalemma increases Ca2+ sensitivity of 
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the BK channel and increases K+ conductance (25). Loss of direct association of BK-β1 
with BKα predicts a diminution of Ca2+ sensitivity and thus attenuation of channel 
function, hyperpolarization and vasorelaxation. Although PKG does not directly 
phosphorylate BK-β1, PKG and Rho kinase can both phosphorylate RAB11a, which 
promotes rapid trafficking of BK-β1 to the plasmalemma and binding to BKα (22). 
Our working hypothesis was that protein colocalization represents the potential 
for protein-protein interaction and therefore function. Correspondingly, any change in 
structural organization that results in a loss of colocalization should represent a loss of 
potential for protein-protein interaction and decreased function.  To test this idea, we 
used confocal microscopy to measure protein colocalization and thereby estimate the 
potential for protein-protein interaction within the limits of voxel resolution 
(≈146x146x545 nm). Pairs of proteins tagged with 488 nm (green) or 633 nm (red) 
fluorochromes were visualized in separate confocal images and in merged images 
wherein coincident red and green pixels appeared yellow (Figure 6).  Owing to the 
functional dependence of the labeled proteins on close proximal relationships, we 
interpreted loss of colocalization to imply a loss of PKG function in LTH arteries.  To 
this end, the extent of protein colocalization was quantified non-parametrically by use of 
quadrant analysis (5, 11), and parametrically by determination of the protein proximity 
index. 
 
Quadrant Analysis of Colocalization 
To obtain a non-parametric analysis of colocalization, the experimental approach 
employed a quadrant analysis of confocal images as previously described (1, 12).  Using 
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this method, individual pixels were assigned to a quadrant based on their separate red 
(low or high) or green (low or high) signal intensities. Pixels thus grouped were weighted 
equally; differences in signal intensities within a quadrant were not considered. The 
power of this analytic technique was most useful in visualizing and quantifying shifts 
between quadrants and changes in population distributions under varying conditions. For 
each of the protein pairs examined, the effect of LTH on middle cerebral arteries showed 
a strong shift from Q1 (high red, high green) to Q3 (low red, low green), indicating a 
large reduction in colocalization of these proteins in response to hypoxic stress (Figure 
7). This was observed for both fetal and adult arteries; each of the Normoxic-Hypoxic 
contrasts for each of the six protein pairs represented in Figure 7 were strongly 
significant, suggestive of an important structural reorganization in response to LTH.  This 
finding was consistent with a reduced ability of PKG to depress contractile tone 
following LTH. 
 
Protein Proximity Index Analysis of Colocalization 
To corroborate the above non-parametric quadrant analysis, we also performed a 
parametric “protein proximity index” (PPI) analysis, using the same images used for the 
quadrant analysis.  This approach enhanced the rigor of the colocalization analysis 
because the two methods relied on distinctly separate algorithms and underlying 
assumptions. As such, the PPI method was designed to be more sensitive to the full range 
of signal intensities and thus constitutes a fully parametric analysis. The calculated 
protein proximity index values revealed a strong loss of colocalization among eight of the 
twelve protein ratios examined (Figure 8), and largely corroborated the quadrant analysis.  
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Interestingly, the four protein ratios that did not exhibit an apparent loss of colocalization 
all had BKα subunit values in the denominator, suggesting that hypoxic decreases in BKα 
subunit abundance offset the associated decreases in colocalization expressed in the 
numerator of the PPI ratios.  Conversely, hypoxic changes in the PPI ratio were most 
robust when the denominator values were associated with proteins, including PKG and 
BK β1, that did not change in response to LTH.  Overall, two quite distinct and 
independent analytical methods, quadrant and PPI analysis, supported a similar 
interpretation:  LTH strongly attenuated colocalization among three highly interactive 
proteins that together governed the effects of PKG on vascular tone.  
 
Perspectives and Significance 
In summary, this investigation revealed that acclimatization to long-term hypoxia 
depressed PKG-mediated attenuation of vasoconstriction in cerebral arteries through a 
modest heterogeneous effect on pKa, and significant effects on BKα abundance and 
BKα/BK-β1/PKG colocalization. Together, the results suggest that loss of PKG-mediated 
attenuation of vasoconstriction following acclimatization to LTH involves multiple 
factors, the most important of which is decreased interaction of PKG with BKα and BK-
β1.  In aggregate, the results predict a loss of efficacy for therapeutic strategies reliant on 
the NO pathway for which PKG is the main endpoint effector. These include exogenous 
NO, its precursors, and phosphodiesterase inhibitors, all of which are commonly 
prescribed. Hypoxic loss of PKG efficacy could potentially affect individuals 
acclimatized to chronic hypoxia, either by extended excursion to high altitude, or by 
predisposing medical conditions that include perinatal hypoxic stress, such as maternal 
 87 
smoking, placental insufficiency, or lung disease.  Treatment and management of these 
pathologies deserve further investigation, particularly in relation to therapeutic 
manipulation of the NO/cGMP/PKG pathway.  
The analytical utility of confocal microscopy has evolved dramatically during the 
past decade, and an ever growing armamentarium of new tools has facilitated novel 
insights into the important relations between protein organization and cell function.  In 
the present study, the use of confocal microscopy helped demonstrate that three key 
proteins that govern cerebrovascular tone disengage spatially under conditions of LTH, 
and that this loss of organization correlates strongly with attenuation of their known 
functions. These findings augment an emerging awareness in vascular biology of 
regulatory systems that rely on changes in molecular trafficking and dynamic subcellular 
organization. Although the present results strongly suggested hypoxic changes in 
vascular protein organization, the findings were limited by the voxel dimensions of the 
analyzed images, which were an order of magnitude larger than the size of the proteins 
being studied.  Clearly, changes in colocalization alone do not definitively prove changes 
in direct protein interaction.  Such proof will require higher resolution measurements of 
protein-protein proximities by use of FRET, proximity ligation assays (PLA), or by 
super-resolution microscopy.  Aside from this limitation, this present investigation 
introduces a new paradigm for hypoxic adaptation: namely that apart from changes in 
abundance and phospho-status, changes in subcellular protein location, trafficking and 
temporospatial relationships represent a dominant mechanism whereby chronic hypoxia 
regulates vascular reactivity, remodeling and structure-function relations.   
  
 88 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Effects of 8-pCPT-cGMP and hypoxia on 5-HT potency and concentration-
response relations:  Figure 1a: Pretreatment with graduated concentrations of 8-pCPT-
cGMP determined the optimal concentration for investigating attenuation of vascular tone 
in ovine middle cerebral arteries. This approach demonstrated that hypoxia attenuated 5-
HT-induced contraction in both fetal and adult arteries at the optimal concentration of 30 
µM. Figure 1b: Adult hypoxic arteries exhibited modestly greater contractile responses 
and 5-HT potency compared with normoxic arteries. Increasing 8-pCPT-cGMP 
concentrations significantly attenuated 5-HT potency in all but the fetal hypoxic arteries. 
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Figure 2. Effects of 8-pCPT-cGMP and hypoxia on occupancy-response relations for 5-
HT:  5-HT receptor affinity was determined for each experimental group using the 
Furchgott method (pKa, Figure 2a). The 5-HT concentration-response relations were 
converted to occupancy-response relations using pKa values to correct for differences in 
agonist binding affinity. The resulting occupancy-response relations revealed that, 
compared with untreated control arteries, pretreatment with 30 µM 8-pCPT-cGMP 
significantly reduced maximum efficacy for 5-HT in normoxic (Figure 2b, left panels) 
but not hypoxic (Figure 2b, right panels) arteries from both age groups. *Significant 
differences (P < 0.05, repeated measures anova) between untreated and treated (30 µM 8-
pCPT-cGMP) arteries. Error bars indicate means ± SE for n ≥ 5 for all groups.  
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Figure 3a. PKG isoforms:  The abundance of total PKG was determined by Western blot 
analysis using an antibody against a PKG-I epitope common to both the α and β isoforms. 
All abundances were calculated relative to known amounts of a standard pool prepared 
from normoxic adult arteries. Figure 3b. *Relative abundance of PKG-Beta was 
significantly greater in fetal than adult arteries but was not affected by hypoxia. Figure 3c. 
PKG activity:  Whole artery PKG activity in middle cerebral arteries (line graphs, pmol-
Pi/unit PKG) was not significantly affected by hypoxia in either fetal (left panel) or adult 
(right panel) homogenates. When whole artery PKG activity was normalized relative to 
PKG abundance (panel insets), estimates of specific activity (pmol Pi/min/unit PKG) did 
not vary significantly with hypoxia or between fetal and adult artery homogenates. These 
data indicate that the ability of hypoxia to ablate the effects of PKG on 5-HT contractions 
was not due to changes in PKG abundance or kinase activity. Error bars indicate means ± 
SE for n ≥ 6. 
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Figure 4a. Effects of iberiotoxin, 8-pCPT-cGMP, age, and hypoxia on 5-HT 
concentration-response relations. Maximum contractile responses to graded concentrations 
of 5-HT varied moderately with age and hypoxia in untreated arteries. Maximum 
contractile responses in iberiotoxin-treated arteries were significantly greater in adult 
normoxic arteries compared with adult hypoxic arteries. Pretreatment with 30 µM 8-pCPT-
cGMP *significantly attenuated 5-HT efficacy in a concentration-dependent manner in 
normoxic fetal and adult arteries. In arteries pretreated with 30 μM 8-pCPT-cGMP, 5-HT 
efficacy was greater in hypoxic compared with normoxic arteries for fetal but not adult 
arteries. Figure 4b. Vasorelaxation attributable to the BK channel vs. non-BK channel was 
determined using an algebraic model. Non-BK channel influence was of greater magnitude 
in all subgroups (FN, FH, AN, AH); whereas BK channel effects were more sensitive to 
LTH, particularly in fetal arteries. Error bars indicate mean ± SE for n ≥ 6 for all groups. 
*Significance (P < 0.05)  
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Figure 5a. The abundance of total BK-alpha and beta1 isoforms was determined by 
Western blot analysis using an antibody against a specific epitope in each of the α and β 
isoforms. Figure 5b. All abundances were calculated relative to known amounts of a 
standard pool prepared from normoxic adult arteries. *Relative abundance of BK-alpha 
was significantly attenuated 46% by hypoxia in fetal cerebral arteries. Abundance of BK-
beta1 was not significantly influenced by chronic hypoxia.  ANOVA analysis showed a 
significant influence of hypoxia on fetal BK-alpha abundance, but no significant 
interactions of maturity with hypoxia for either BK-alpha or -beta1 protein abundances.  
Error bars indicate means ± SE for n ≥ 6.  
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Figure 6. The first row in the above graphic represents the distribution of BKα protein 
(red) and BKβ1 protein (green). The merged images appear as shades of yellow where the 
two proteins are colocalized within the resolution of the acquired images. Voxel 
dimensions were ≈146x146x545 nm @488 nm (red); ≈185x185x693 nm @ 633 nm 
(green). Hypoxic artery segments in both fetal and adult arteries appeared visibly less 
yellow, and thus represented less colocalization in that protein pair. The second row 
represents PKG (red) and BKα (green). These merged images likewise appeared visually 
to possess less colocalized protein for both fetal and adult hypoxic arteries. The third row 
represents PKG (red) with BKβ1 (green) protein. Images represent a field of approximately 
180x180 µm (scale inset, lower right panel). Histological changes in the hypoxic arteries 
were also apparent; the medial layer was thinner and less invested in fusiform cell 
morphology, suggesting a probable shift in smooth muscle phenotype. 
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Figure 7a. Representative scattergrams for fetal normoxic and hypoxic middle cerebral 
arteries illustrate a substantial loss of protein colocalization secondary to chronic hypoxia. 
Likewise, each of the six protein pairs exhibited qualitatively similar scattergrams (not 
shown). For protein pairs shown (BKα with BKβ1, fetal normoxic and hypoxic), the 
vertical axis (λ633, red) represents BKα, and the horizontal axis (λ488, green) represents 
BKβ1 across the full resolution (intensities 0-255) of the analysis software. Figure 7b. 
Quadrant 1 (upper right in each scattergram) colocalization expressed as a fraction of the 
total shows that chronic hypoxia had a significant effect on all three protein pairs (BKα 
with BKβ1, PKG with BKα, and PKG with BKβ1) in both fetal and adult arteries. Maturity 
(fetal vs. adult) displayed a modest but not significant trend in colocalization of BKα with 
BKβ, and PKG with BKβ1 protein pairs in normoxic cerebral arteries (black bars). 
Maturity had no significant effect on colocalization of these protein pairs among hypoxic 
arteries (gray bars). *Significance (P < 0.05).  
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Figure 8a:  A three-dimensional mesh plot depicts the cross-correlation surface from an 
adult normoxic artery image stained for BKα and BKβ1. The horizontal scales represent a 
measure of Gaussian shift ±100 units from the peak intensity; the vertical scale represents 
signal intensity. The slow-decay portion of this surface (blues and yellows) represents a 
pseudo-correlation subset and is filtered from further analysis. The rapid-decay surface 
(oranges and reds) represents presumed protein-protein interactions (38). This cross-
correlation surface, plus the auto-correlation surface for each individual protein of interest 
(not shown) provides a basis for computing the protein proximity index (PPI). Figure 8b, 
Lower left image:  A contour plot from the same data as above, showing the “slice” (black 
straight line) that defines a cross-section for purposes of equation-fitting of the grid data. 
The cross-section always bisects the peak of each mesh plot and includes the rapid-decay 
surface. Figure 8c, Upper right image: This PPI histogram shows that long term hypoxia 
(LTH) significantly (*) depressed colocalization of BKα with BKβ1 as a ratio of total BKβ1 
protein [(BKα+BKβ1)/BKβ1] in both fetal (F) and adult (A) arteries (first panel). LTH also 
depressed the [(PKG+ BKα)/PKG] and [(PKG+ BKβ1)/PKG] PPI indices in both fetal and 
adult arteries (panels 3 & 4). LTH had less influence on the PPI index of BKα colocalized 
with BKβ1 expressed as a ratio to total BKα [(BKα+BKβ1)/BKα] (panel 5). Maturity 
showed a small but significant (§) influence on the [(BKα+BKβ1)/BKβ1] PPI index as well 
as the [(PKG+BKα)/BKα] and [(PKG+BKβ1)/BKβ1] indexes among hypoxic but not 
normoxic arteries (panels 2, 5, 6).  
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CHAPTER FOUR 
DISCUSSION 
 
Future Directions 
Investigation of Spontaneous Iberiotoxin-induced Contractions 
It is the nature of the scientific process to formulate hypotheses, and then to 
design experiments to validate or refute a particular hypothesis.  Sometimes in the course 
of this process there is an unexpected finding that represents alternatively an 
experimental failure, or a surprising new discovery. Such is the case with early results in 
this investigation.  Based on earlier work with carotid arteries, it was reasonably expected 
that functional studies in middle cerebral arteries would behave similarly, both with 
regard to response to the vasocontractant (5-HT) and vasorelaxant (8pCPT-cGMP), as 
well as changes secondary to chronic hypoxia, albeit of potentially different amplitudes 
and reactivity given the differences in size and anatomical proximity to the cerebral 
tissues they service. The following represents heretofore unpublished incidental findings 
obtained during the course of the main study that deserve further investigation. 
In the late summer of 2013 as hypoxic tissues became available from the high-
altitude sheep herd, functional contractility studies commenced with careful attention to 
experimental details in order to minimize variability and to produce accurate results. In 
order to measure the influence of PKG on the BK channel under conditions of chronic 
hypoxia, a subset of arteries was pre-treated with iberiotoxin (100nM) to inhibit BK 
potassium currents, as described in the original carotid article (5).  It was expected that 
contractile forces would increase with the iberiotoxin-induced loss of hyperpolarization, 
when measured as a difference in force with reference to a resting baseline force and 
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normalized to a percentage of maximum potassium contractile force. Unexpectedly, the 
opposite occurred. Force differences in iberiotoxin-treated arteries compared with 
baseline values showed a decrease in contractile force, suggesting that iberiotoxin was a 
powerful vasorelaxant. This could not be true; there was no theoretical framework that 
could account for such an experimental result.  The planned series of experiments was 
suspended; hypoxic tissues were subsequently invested in organ culture for imaging 
studies, and a limited budget of hypoxic cerebral arteries were invested in learning what 
went wrong with the above functional contractility results. The real cost of this was 
having to wait another full year for the next “hypoxic season” to repeat the set of 
experiments. 
An investigation ensued to learn what went wrong with the iberiotoxin-treated 
artery functional studies. The protocol at the time was to turn the data recorder on and off 
at precise intervals when specific reagents were added to the artery bath, or during 
concentration-response intervals. As a first step, the protocol was revised to leave the 
recorder on for the full duration of a given experiment, and a variety of experimental 
conditions were employed to learn what might account for the previous unexpected 
findings.  To our surprise, a subset of hypoxic cerebral arteries exhibited a strong 
spontaneous contraction, which consistently returned to baseline after several minutes 
(Figure 1).  The start point of these contractions was quite variable, and not all arteries 
exhibited this phenomenon. The failure or inability to anticipate this “anomaly” 
previously resulted in “miscalculating” a contractile force as a difference from an 
observed “baseline” that was not actually representative. 
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This represents a newly observed phenomenon not previously reported in the 
literature, and deserves further investigation.  Subsequent functional studies by this lab in 
the “hypoxic season” of late summer 2014 used a modified protocol that fully accounts 
for unwanted spontaneous contractions; the data is now believed to be correct and 
accurate (Chapter Three of this dissertation). 
Several observations regarding this phenomenon are worth noting: 1) We have 
observed this only in hypoxic, but not normoxic cerebral arteries, 2) this was not 
observed in carotid arteries, 3) not all iberiotoxin-treated arteries display this behavior, 4) 
the onset of a spontaneous contraction is highly variable as measured from the moment of 
iberiotoxin treatment, 5) this has occurred in both fetal and adult arteries, and 6) each 
spontaneous contraction returns consistently to, or very near, the original baseline value.  
It remains to be investigated as to the physiology of the cause and the spontaneous 
reversal of these contractions.  It might be speculated that positive feedback from 
calcium-dependent calcium release from the SR results in a runaway calcium wave 
unchecked by BK influence, which might then lead to a depolarization that opens 
voltage-gated calcium channels. Given that fully iberiotoxin-ligated BK channels remain 
~50% conductive (2), these might likely be involved with ultimate 
repolarization/hyperpolarization of the vascular smooth muscle and return to normal 
vascular tone.  Understanding the physiology of this phenomenon would be a candidate 
for further investigation. 
Given that the above experimental conditions involve potentially lethal doses of 
iberiotoxin, this may seem clinically irrelevant. But to the contrary, iberiotoxin-ligated 
BK channels may represent a useful model of BK-deficient VSMC that, by previous 
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exposure to chronic hypoxia or other pathologies, experience spontaneous strong 
contractions, as in the cerebral vasospasm that is known to accompany the migraine 
phenomenon, and other clinical entities.  
  
 105 
 
 
 
Figure 1. Iberiotoxin-induced spontaneous contractions.  Hypoxic adult ovine middle 
cerebral arteries exhibit spontaneous contractions in the absence of 5-HT.   The horizontal 
axis represents time (in seconds) from initial application of iberiotoxin. Start times post 
iberiotoxin treatment is widely variable, but the duration is typically on the order of about 
400 seconds, as in the above examples. Contractile force typically returns completely to 
baseline tension.  
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Examination of BK Channel Protein Phospho Status 
The BK alpha protein has over 200 serine/threonine residues that are potential 
targets for AGC kinases (6).  Several of these have been studied in great detail with 
regards to regulation of channel activity as well as a seeming interaction of several AGC 
kinases competing for closely associated serine residues (7).  An interesting 
“phosphorylation logic” plays out on the BK-alpha protein, whereby action by PKA on 
Ser922, or action by PKG on Ser1134 increases calcium sensitivity. These two events are 
mutually exclusive. It has been shown that action by PKC on the tandem Ser1151 and 
Ser1154 will enable PKG to phosphorylate Ser1134 and disable PKA action on Ser922.  
Conversely, inhibition of PKC switches the influence of BK Channel activation from 
PKG to PKA (7).  Briefly, the effect of prior action by PKC tips the balance of influence 
in favor of PKG at the expense of PKA. This has not been investigated in the context of 
chronic hypoxia. It would be of interest to examine the phospho status of the BK alpha 
protein Ser922, Ser1134, Ser1151 and Ser1154 in hypoxic and normoxic tissues.  This 
could be accomplished using specific antibodies, or possibly mass spectrometry. 
Another line of investigation of this same issue would be to specifically 
manipulate the phosphorylation state of the BK-alpha protein by activation of 
phosphatases to dephosphorylate the above serine residues, then to selectively activate 
PKC followed by PKG activation, and measure the effect of this on colocalization of 
PKG/BK-alpha/BK-beta proteins.  A separate functional outcome would be the effect of 
this on the ability of PKG to induce vasorelaxation on these manipulated arteries.  The 
experiment would then be repeated in the reverse order: activation of PKG first, followed 
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by PKC activation, then compare results.  This could potentially replicate in vitro the 
influence of chronic hypoxia, which would be of high theoretical interest.  
 
High-Resolution Studies of Contractile Protein Colocalization 
A limitation of the use of confocal microscopy in this investigation was the voxel 
dimension, as mentioned previously. This is an inherent limitation based on the resolving 
power of a given wavelength of light. This localizes protein within a linear separation 
range of 0-583nm. A logical next step would be to repeat the colocalization experiments 
using a proximity ligation assay (PLA) which has a resolution on the order of 40 nm, 
sufficient to infer direct protein-protein contact and a probable functional interaction.  
This could be accomplished using the same tissue blocks that were used for the above 
confocal microscopy analysis.  Super-resolution microscopy offers a comparable increase 
in resolving power, although the exact resolution depends on the wavelength and other 
experimental conditions.  
 
Investigation of BK Channel Alternate Splicing in Chronic Hypoxia 
Multiple splice sites exist on the BK-alpha (KCNMA1) gene, which yields no less 
than twelve, and possibly upwards of twenty or more splice variants (3). The role of 
hypoxia in controlling splice variants and regulating calcium sensitivity remains to be 
explored, although it is understood to be tissue-specific and responsive to environmental 
stress. The refractory nature of the BK channel with regard to PKG-induced 
vasorelaxation in conditions of chronic hypoxia could well have an underlying splice-
variant mechanism; the existence or absence of a PKG serine residue target would 
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obviate any attempt to activate PKG and expect an observable result. Mass spectrometry 
determination of BK-alpha protein sequence would be useful to address this issue. 
 
Investigation of BK Channel Protein Trafficking by RAB11a 
The BK-beta1 proteins are typically more abundant than the BK-alpha 
counterparts within vascular smooth muscle. The two proteins are independently 
regulated. However, the excess abundance of BK-beta1 does not imply that the 
association of BK-beta1 with BK-alpha is saturated. Rather it is highly regulated.  BK-
beta1 is rapidly trafficked by RAB11a when it (RAB11a) is activated by PKG (Leo, 
2014). This raises an interesting question of whether PKG is ineffective in activating 
RAB11a under conditions of chronic hypoxia. Failure of RAB11a to efficiently transport 
intracellular BK-beta1 to the plasmalemma could potentially explain the observed 
alterations in protein organization that were reported in the above colocalization studies. 
And experimental approach might first examine the phospho status of RAB11a in 
response to PKG activation, and in conditions of hypoxia and normoxia. Additionally, 
colocalization of BK-beta1 with RAB11a, or PKG with RAB11a could be examined 
under the same conditions. Of additional interest would be maturation (adult vs. fetal) 
would influence this dynamic.  
 
Potential Therapeutic Rescue of Hypoxia-Damaged Vascular Tissue 
The influence of PKG in promoting and maintaining the contractile phenotype is 
well-established, and is in part mediated by direct and indirect action on the CREB 
pathway (4).  Loss of contractile phenotype within VSM is accompanied by a loss of 
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vasorelaxation potential and PKG efficacy. Therapeutic strategies that rely on the NO 
pathway may likewise fail when the main effector of the pathway, PKG, is itself 
ineffective, as is the case with hypoxia-damaged arteries. Yet therapies, or even 
experimental techniques to reverse the loss of PKG efficacy secondary to LTH don’t yet 
exist. It is tempting to speculate that CREB activators might hold the potential to restore 
the expression of contractile proteins, and thereby the contractile phenotype and PKG 
efficacy. If that were possible, the protocols used in this investigation would serve as a 
convenient assay to screen and evaluate candidate therapies.  In particular, the functional 
contractility methods, and the protein colocalization assay would represent a cost-
effective screening tool. Recent reports describe the use of the experimental drug J147, a 
CREB activator, that shows promise in restoring structure and function among neuronal 
and related tissues (1). Given the pathways involved, there is at least a theoretical 
potential for this agent, or another CREB activator, to influence the VSM phenotype, 
although the effects of this on VSM has not been described. 
 
Conclusions 
It is the nature of scientific investigation that by answering a specific question, more 
questions appear, seemingly exponentially. This is no exception. This study has 
confirmed earlier observations regarding the influence of hypoxia on PKG efficacy, and 
has offered measures of protein abundance and kinase activity that suggest other 
explanations are needed. Of interest, we have shown that protein organization is 
profoundly influenced by chronic hypoxia, and that this correlates strongly with the 
functional endpoints that were measured. Questions that remain unanswered are the 
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factors that contribute to the observed changes in protein organization. These include 
questions about the channel protein phospho-status, trafficking of the BK channel 
proteins, alternate splicing, and specific modes of interaction of these with chronic 
hypoxia.  That suggests a much larger investigation. By addressing these issues, this 
carries the potential for devising new therapeutic strategies that will ultimately reduce the 
health risks associated with chronic hypoxia and improve the quality of human life. 
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